annual meeting brochure 2015_Layout 1 10/04/ :32 Page 1 26th - 29th APRIL

Transcription

1 26th - 29th APRIL

2 CONTENTS PRESIDENT'S WELCOME 3 COMMITTEES & CHAIRS 4 GENERAL INFORMATION 5-6 OVERSEAS INVITED SPEAKERS 9-11 SOCIAL EVENTS 12 PLENARY SESSIONS 13 AT A GLANCE PROGRAMME BOOT CAMP 14 MONDAY TUESDAY 16 WEDNESDAY 17 FULL PROGRAMME 18- BOOT CAMP MONDAY TUESDAY WEDNESDAY 29- POSTERS EXHIBITION FLOOR PLAN EXHIBITOR PROFILES A-Z VENUE PLAN 42 BRIGHTON MAP 43 Design nd printed by Nottinghm

3 BNMS PRESIDENT'S WELCOME Welcome to BNMS nnul meeting 20 On behlf of the British Nucler Medicine Society, it is plesure to welcome you to the 43rd nnul spring meeting in Brighton. The meeting will kick off with the ever populr Boot Cmp Progrmme which now hs prllel clinicins nd prctitioner s sessions. The min meeting this yer hs very diverse progrmme which ddresses wide vriety of topics rnging from cutting edge dvnces in science nd clinicl prctice to updtes in routine investigtions in dily prctice with over 20 invited expert spekers nd dozens of CPD lectures. I m prticulrly looking forwrd to the nnul lecture delivered by Professor Mcpinlc on the Evolving role of clinicl moleculr imging in multi-disciplinry cncer cre. This yer we lso hve n extensive number of dily focused msterclsses, on topics rnging from PET nd therpy, to trditionl nucler medicine prctices. In ddition the meeting is forum for presenting your own ongoing reserch nd ctching up with reserch from ll over the world with over 200 bstrct nd poster presenttions. You will lso hve chnce to identify nd discuss the chnging scene in trining nd regultory spects of nucler medicine which ffects us ll. This yer is specil yer, I m excited to nnounce the specil event we re hving to celebrting the 25th nniversry of the estblishment of the BNMS Clinicl Prctitioners Group (formerly known s the Technologists Group), one of the first in the Europe. This is gret opportunity to meet pst nd present members of this group nd remember nd celebrte chievements of the pst 25 yers. Do not miss the finl dy of the conference which will end trditionlly with lecture to give you n overview nd highlights of the meeting, which I m delighted to sy tht Dr Brin Neilly hs kindly greed to undertke. The lst dy of the meeting is lso the occsion when we celebrte the best, by wrding the prizes for best proffered presenttions nd posters delivered in the course of this three dy event. I would like to personlly thnk the tireless efforts of Prof Bomnji nd Dr Gnnsegrn in orchestrting such n excellent nd promising progrmme. I hope you will enjoy the meeting, tking wy with you mny memorble moments from the tlks nd lectures, the event itself nd of course the beutiful seside resort of Brighton. To mke it ll esier for you we re lunching our new pp for mobile devices, which will enble you to nvigte through the progrmme stremlining your selections nd choices. Finlly I would like to remind you tht plns re lredy in plce for very exciting BNMS nnul spring meeting in Birminghm next yer, when we shll be celebrting the 50th nniversry of the British Nucler Medicine Society. Dr Alp Notghi BNMS President BNMS 43rd Annul Meeting 3

4 COMMITTEES & CHAIRS SCIENTIFIC COMMITTEE Dr J Bomnji (Chir) Ms S Allen Dr P Arumugm Dr J Bllinger Dr T Brwick Dr A Bolster Mr A Brdley Mrs J Crosdle Dr B Drke Dr B Ellis Dr G Gnnsegrn Dr S Hn Dr S Hughes Dr C Mrshll Mr L Rowling Dr P Ryn (Poster Chir) Dr F Sundrm 4 BNMS 43rd Annul Meeting COUNCIL MEMBERS 20/2016 Dr A Notghi Dr B Neilly Ms S Allen Prof S Vinjmuri Dr G Flux Dr R Grhm Ms C Greves Ms J Crosdle Dr M Hll Dr K Wechlekr Mr Lloyd Rowling Dr D Nerimn, Dr A Corrign Mr M Wrd Ms C Lory Dr S Dizdrevic Mrs D Tolley Dr B Ellis Dr J Bomnji Dr G Gnnsegrn CONFERENCE ORGANISATION Scientific Chir Eduction Chir Poster Session Orgniser YIP judging Conference Secretrit President Pst-President Hon Secretry Hon Tresurer Professionl Stndrds Committee BNCS President Clinicl Prctitioners Group Medicl Trinee NMC News & Views NM Industry Assocition Nurse PET-CT & Membership & PR Ptient Representtive Rdiophrmceuticl Sciences Group Scientific Committee Eduction Committee Dr J Bomnji Dr G Gnnsegrn Dr P Ryn Dr F Sundrm Prof S Vinjmuri Ms C Weston, Ms N Fenning, Mrs E Gilbert POSTER JUDGES Srh Allen Dr Prth Chudry Dr Sbin Dizdrevic Dr Si Hn Andy Irwin Dr Vikrm Lele Dr Nicol Mulhollnd Dr Khlid Nwz Dr Emmnouil Pngiotidis Dr Ngbhushn Seshdri Chistopher Sibley-Allen Dr Shnmug Sundrm Dr Frncis Sundrm Dr Teres Syzskho Dr Tghreed Tom Dr Kshm Wechlekr CHAIRMEN Dr Rosemry Alln Srh Allen Dr Prthibn Arumugm Smer Bngsh Dr Lorenzo Bissoni Mri Burniston Dr Alexis Corrgin Jilly Crosdle Ktherine Dy Penny Delf Dr Sbin Dizdrevic Dr Brent Drke Dr Yong Du Dr Beverley Ellis Dr Gopinth Gnnsegrn Dr Richrd Grhm Dr Si Hn Pul Hinton Dr Simon Hughes Prof Drzen Huic Dr Brin Hutton Dr Jckie Jmes Sndr Johns Dr Irfn Kyni Dr Vikrm Lele Prof Jsn Mihilovic Dr N Mulhollnd Dr Ngesh Ngbhushn Dr Shunk Nvlkissoor Dr K Nwz Dr Brin Neilly Dr Alp Notghi Prof Aln Perkins Dr Vineet Prksh Dr Robert Reid Lloyd Rowling Dr Pul Ryn Dr Andrew Scrsbrook Dr Frncis Sundrm Dr Rizwn Syed Dr Teres Szyszko Dr Rghuveer Venknngri Prof Sobhn Vinjmuri Dr Kshm Wechlekr Dr Wi-Lup Wong

5 GENERAL INFORMATION APP This brochure is vilble s n APP to downlod. See the QR codes in the foyer nd on the BNMS Stnd AV ROOM The AV nd Preview Room is locted on the 1st Floor Opening times: Sundy Mondy Tuesdy Wednesdy BADGES For orgnistionl nd security resons, bdges must be worn t the congress venue. Access to the conference res will only be grnted upon presenttion of your bdge. BNMS STAND & INTERNET ACCESS Computers with internet ccess re vilble on the BNMS Stnd in the Exhibition Hll BOOK OF ABSTRACTS This is vilble in the ltest edition of Nucler medicine communictions which cn be found in the delegte bg. iphone, ipd nd Android users cn view n electronic version of NMC My 20 Edition which contins the bstrct. Scn the QR code in the progrmme or follow the link in the pp for new wy to experience the conference CATERING Cfe Est situted on 1st floor will be open for the durtion of the meeting selling hot nd cold beverges, confectionery, sncks nd sndwiches" Lunch nd refreshment breks re included for ll delegtes in the exhibition hll on Mondy nd Tuesdy. A 'grb bg' lunch will be vilble for delegtes on Wednesdy CLOAKROOM A clokroom is vilble for delegte use in the min reception re. CME/CPD CPD pprovl hs been sought from the Federtion Royl Colleges of Physicins. Delegtes cn only record the ctul number of hours ttended for CME/CPD purposes. Plese note: CME/CPD certifictes will be vilble for downloding from the BNMS website fter the meeting, using your delegte ID number. COMMERCIAL EXHIBITION - 1st Floor Mondy Tuesdy CONFERENCE REGISTRATION On-line Registrtion only: After Wednesdy 22nd April Tel: Emil: office@bnms.org.uk EMERGENCY CONTACT NUMBER The emergency contct telephone number for delegtes ttending the conference is FUTURE BNMS MEETINGS The BNMS Autumn Meeting 20 will tke plce t the Royl Society of Medicine, London on Wednesdy 2nd September. The BNMS Spring Meeting 2016 celebrting 50 yers of the Society will tke plce t the ICC Birminghm on 17th 19th April HOTEL ACCOMMODATION See hotel listing nd booking form on the BNMS website Telephone or emil delegtes@visitbrighton.com INTERNET ACCESS Free internet ccess is vilble for delegtes in the Exhibition Hll on the BNMS stnd no.26. DELEGATE BAGS Kindly sponsored by Bright Technologies LANYARDS Kindly sponsored by Philips PADS Kindly sponsored by Lilly UK BNMS 43rd Annul Meeting 5

6 GENERAL INFORMATION PENS Kindly sponsored by Lilly UK PRE-REGISTRATION Meet nd Greet Reception Sundy 26 April Foyer, Brighton Convention Centre. POSTER DISPLAY AND JUDGING EXHIBITION HALL Mondy Posters P1 P52 Tuesdy Posters P53 P114 PRIZES FOR PROFFERED PAPERS AND POSTERS ORAL PRESENTATION 1st 0 plus President s Cup Sponsored by Philips 2nd 0 Sponsored by Philips 3rd 50 Sponsored by Philips POSTER PRESENTATION 1st 0 2nd 0 3rd 50 CLINICAL PRACTITIONER ORAL 0 Provided by n eductionl grnt from Mllinckrodt CLINICAL PRACTITIONER POSTER 0 Provided by n eductionl grnt from Mllinckrodt MULTIMODALITY ORAL PRIZE 350 Sponsored by Hermes MULTIMODALITY POSTER PRIZE 250 Sponsored by Hermes RADIOPHARMACY ORAL PRIZE 250 Sponsored by Allince Medicl RADIOTHERAPY PRIZE NEW FOR 20 1st 0 Sponsored by Byer 2nd 0 Sponsored by Byer 3rd 50 Sponsored by Byer Pge 6 BNMS 43rd Annul Meeting STUDENT PRIZE 1st 100 nd free registrtion wrded by BNMS on bstrct submission lone 2nd nd 3rd Prize winners receive certificte REGISTRATION DESK OPENING TIMES For Boot Cmp Sundy 26th April. For Min Meeting: Sundy Preregistrtion nd Meet nd Greet Reception t Mondy Tuesdy Wednesdy SPECIAL INTEREST GROUPS Mondy Clinicl Scientists Forum - Syndicte Clinicl Prctitioner Group AGM Meeting Room Medics forum Meeting Room 5 Tuesdy Rdiophrmceuticl Sciences Group AGM - Syndicte Trinees Forum - Syndicte BNMS Members AGM - Auditorium 2 SOCIAL MEDIA Follow us on #BNMS20 #BNMSbootcmp #BNMSbrighton SOCIETY MEMBERSHIP Membership of the British Nucler Medicine Society is open to those who hve substntil interest nd involvement in the development nd provision of Nucler Medicine services. The Society exists to further the professionl, scientific nd clinicl interests of members nd to support the development of Nucler Medicine for the benefit of ptients. SUBCRIPTION RATES UK Full member 132 Overses Full member 172 Full member reduced rte 108 Associte Member 60 Further detils re vilble t the Conference Registrtion Desk or by visiting our website ( WIFI Wifi is vilble throughout the conference venue.

7 The first dignostic PET trcer licensed for imging bet-myloid plque density in dult ptients undergoing evlution for Alzheimer s disese nd other cuses of cognitive impirment. Amyvid PET scns re interpreted using binry visul red methodology (negtive/positive) INTRODUCING AMYVID NEGATIVE SCAN 1 POSITIVE SCAN 1 ACCURATE: 92% sensitivity (95% CI: 78% to 98%) nd 100% specificity (95% CI: 80% to 100%) for detection of corticl neuritic plque density (bsed on the mjority of blinded PET reding by 5 nucler medicine physicins) 1 EFFECTIVE: Amyvid nd utopsy results gree 2 RELIABLE: Demonstrted inter-reder reproducibility 2 Indictes sprse or no density of corticl bet-myloid plques 1 FAVOURABLE TOLERABILITY AND CONVENIENCE FOR YOUR PATIENTS: No fsting or glucose monitoring is required Is not consistent with dignosis of AD 1 OFFERS AN EFFICIENT ENT IMAGING EXPERIENCE 1 Indictes moderte to frequent density of corticl bet-myloid plques 1 Does not independently estblish dignosis of AD or other cognitive disorder since neuritic plque deposition in grey mtter my be present in symptomtic elderly nd some neurodegenertive dementis (AD, Lewy body dementi, Prkinson s disese dementi) 1 Plese visit the Lilly Exhibit Booth # 16 for dditionl informtion After Amyvid is injected, AFTER there AMYVID is IS INJECTED, - to 50-minute THERE IS A uptke period to AN AMYVID PET AN SCAN AMYVID TAKES PET SCAN TAKES 10 MINUTES MINUTE MINUTES 24 UPTAKE PERIOD to 60 minutes from trcer injection to scn completion 1 60 minutes of stble imge contrst following -minute uptke Provides flexibility for scheduling nd technicl delys Offers n opportunity for repet scn, if necessry Amyvid imges should only be interpreted by reders trined in the interprettion of PET imges with florbetpir ( 18 F). Plese see Abbrevited Prescribing Informtion on the next pge UKAMY (1) Mrch 20 florbetpir ( 18 F)

8 AMYVID TM (FLORBETAPIR [ 18 F]) ABBREVIATED PRESCRIBING INFORMATION Due to the complex nture of rdiolbelled dignostic gents, plese refer to the Summry of Product Chrcteristics nd pckge informtion before prescribing or dministrtion. These include guidnce for storge, hndling, nd interprettion of the resulting positron emission tomogrphy (PET) scns. Amyvid imges should only be interpreted by reders trined in the interprettion of PET imges with florbetpir ( 18 F). With regrd to interpreting the imges, Reder Trining is vilble. Presenttion Amyvid 800 MBq/ml: Ech ml of solution for injection contins 800 MBq of florbetpir ( 18 F) t the dte nd time of clibrtion (ToC) (rnges from 800 MBq to MBq). Multidose vils of 10 or ml. Amyvid 1900 MBq/ml: Ech ml of solution for injection contins 1900 MBq of florbetpir ( 18 F) t the dte nd ToC (rnges from 1900 MBq to MBq). Multidose vils of 10 or ml.also contins ethnol, nd sodium (up to 37mg). Uses Dignostic use only. Rdiophrmceuticl indicted for PET imging of β-myloid neuritic plque density in the brins of dult ptients with cognitive impirment who re being evluted for Alzheimer s disese (AD) nd other cuses of cognitive impirment. Amyvid should be used in conjunction with clinicl evlution. Dosge nd Administrtion A PET scn with florbetpir ( 18 F) should be requested by physicins skilled in the clinicl mngement of neurodegenertive disorders. Amyvid imges should only be interpreted by reders trined in the interprettion of PET imges with florbetpir ( 18 F). A recent co-registered computed tomogrphy (CT) scn or mgnetic resonnce (MR) imging of the ptient to get fused PET-CT or PET-MR imge is recommended in cses of uncertinty bout the loction of grey mtter nd of the grey/white mtter border in the PET scn. The recommended ctivity for n dult weighing 70 kg is 370 MBq florbetpir ( 18 F). The volume of the injection should not be less thn 1ml nd not exceed 10ml. Elderly: Dosge djustment not required. Renl nd heptic impirment: Creful considertion of the ctivity to be dministered is required since n incresed rdition exposure is possible in these ptients. The phrmcokinetics of florbetpir ( 18 F) in ptients with renl or heptic impirment hve not been chrcterised. Florbetpir ( 18 F) is excreted primrily through the heptobiliry system nd ptients with heptic impirment hve the potentil of incresed rdition exposure. Method of dministrtion: For intrvenous use. For multidose use. The ctivity of florbetpir ( 18 F) hs to be mesured with n ctivimeter (dose clibrtor) immeditely prior to injection. The dose is dministered by intrvenous bolus injection, followed by flush of sodium chloride 9mg/ml (0.9%) solution for injection to ensure full delivery of the dose. Injection of Amyvid through short intrvenous ctheter (pproximtely 4 cm or less) minimises the potentil for dsorption of the ctive substnce to the ctheter. The injection of florbetpir ( 18 F) must be intrvenous in order to void irrdition s result of locl extrvstion, s well s imging rtefcts. Imge cquisition: A 10 minute PET imge should be cquired strting pproximtely to 50 minutes fter intrvenous injection of Amyvid. Ptients should be supine with the hed positioned to centre the brin, including the cerebellum, in the PET scnner field of view. Reducing hed movement with tpe or other flexible hed restrints my be employed. Reconstruction should include ttenution correction with resulting trnsxil pixel sizes between 2.0 nd 3.0 mm. Contr-indictions Known hypersensitivity to ny ingredient. Wrnings nd Specil Precutions Individul benefit/risk justifiction: For ech ptient, the rdition exposure must be justifible by the likely benefit. The ctivity dministered should, in every cse, be s low s resonbly chievble to obtin the required dignostic informtion. Limittions of use: A positive scn does not independently estblish dignosis of AD or other cognitive disorder since neuritic plque deposition in grey mtter my be present in symptomtic elderly nd some neurodegenertive dementis (Alzheimer s disese, Lewy body dementi, Prkinson s disese, dementi). The efficcy of Amyvid for predicting development of AD or monitoring response to therpy hs not been estblished. After the procedure: Close contct with infnts nd pregnnt women should be restricted during the initil 24 hours following the injection. This medicinl product contins 10 vol % ethnol (lcohol), ie, up to 790mg per dose, equivlent to 20ml beer or 8ml wine per dose. Interctions In vitro binding studies hve not shown interference of florbetpir ( 18 F) binding to β-myloid plques in the presence of other common medicinl products tken by AD ptients. Fertility, Pregnncy, nd Lcttion The risk benefit rtio needs to be ssessed on cse by cse bsis. Driving, etc Not relevnt. Undesirble Effects Adverse rections hve been collected in clinicl studies involving 555 subjects nd 665 dministrtions of Amyvid solution for injection. No serious dverse rections relted to Amyvid dministrtion hve been reported. While they my in relity occur t lower frequencies thn indicted below, the size of the source dtbse did not llow for the ssignment of frequency ctegories lower thn the ctegory uncommon ( 1/1,000 to <1/100). Very common ( 1/10), common ( 1/100 to <1/10), uncommon ( 1/1,000 to <1/100). Common: Hedche. Uncommon: Dysgeusi, flushing, nuse, pruritus, urticri, infusion site rections including rsh, hemorrhge, irrittion, nd pin. Other Informtion Shelf life: 800 MBq/ml is 7.5 hours, 1900 MBq/ml is 10 hours, from the ToC. Ech vil is enclosed in shielded continer of pproprite thickness to minimise externl rdition exposure. Product does not require ny specil temperture storge conditions. Storge of rdiophrmceuticls should be in ccordnce with ntionl regultion on rdioctive mterils.for full detils of these nd other side-effects, plese see the Summry of Product Chrcteristics, which is vilble t Legl Ctegory POM Mrketing Authoristion Numbers EU/1/12/805/ MBq/ml, 1-10ml - 1 vil EU/1/12/805/ MBq/ml, 1-ml - 1 vil EU/1/12/805/ MBq/ml, 1-10ml - 1 vil EU/1/12/805/ MBq/ml, 1-ml - 1 vil Bsic NHS Cost 810/370MBq. Dte of Preprtion or Lst Review August 2013 Full Prescribing Informtion is Avilble From Eli Lilly nd Compny Limited Lilly House, Priestley Rod Bsingstoke, Hmpshire, RG24 9NL Telephone: Bsingstoke (01256) E-mil: ukmedinfo@lilly.com Website: AMYVID TM (florbetpir [ 18 F]) is trdemrk of Eli Lilly nd Compny. UKAMY00103(1) Mrch 20 Adverse events should be reported. Reporting forms nd further informtion cn be found t: Adverse events nd product complints should lso be reported to Lilly: plese cll Lilly UK on References: 1. Amyvid Summry of Product Chrcteristics, Eli Lilly nd Compny. 2. Clrk CM, Pontecorvo MJ, Bech TG, et l; for the AV--A16 Study Group. Cerebrl PET with florbetpir compred with neuropthology t utopsy for detection of neuritic myloid-b plques: prospective cohort study. Lncet Neurol. 2012;11(8):

9 OVERSEAS INVITED SPEAKERS ANNUAL LECTURE SPEAKER: The Evolving Role of Clinicl Moleculr Imging in Multi-Disciplinry Cncer Cre TUESDAY AUDITORIUM 2 Professor Homer A. Mcpinlc Jmes E. Anderson Distinguished Professor & Chir, Deprtment of Nucler Medicine University of Texs M.D. Anderson Cncer Center Houston, Texs Dr. Homer A. Mcpinlc is the Jmes E. Anderson Distinguished Professor of Nucler Medicine nd Chir of the Deprtment of Nucler Medicine t the University of Texs M.D. Anderson Cncer Center in Houston, Texs nd holds joint ppointment in the Deprtment of Cncer Systems Imging. Prior to joining M.D. Anderson, he served s clinicl director of the Lurent nd Albert Gershel PET Center, served s Chief Resident for the Nucler Medicine service, nd completed his Oncologic Imging nd PET fellowship ll t Memoril Slon-Kettering Cncer Center (MSKCC), in New York. Dr. Mcpinlc is n ctive committee member of vrious groups nd societies nd is n expert consultnt for the Interntionl Atomic Energy Agency. He hs over 170 publictions nd is considered ntionl nd interntionl expert in the field of nucler medicine nd positron emission tomogrphy. Dr. Mcpinlc is bord certified by the Americn Bord of Nucler Medicine, with Certificte of Added Qulifiction (CAQ) in Nucler Crdiology. He ws lso elected s fellow of the Americn College of Nucler Physicins. He ws pst-president of the Society of Nucler Medicine PET Center of Excellence nd received the SNM Distinguished Service Awrd for this role. He ws selected s the recipient of the 2014 Vikrm Srbhi Ortion Awrd from the Society of Nucler Medicine Indi. G-68-PSMA PET/CT imging: The Gme Chnger TUESDAY AUDITORIUM 2 ANNUAL LECTURE SESSION Dr K.G.Kllur Director Moleculr Imging Helthcre Globl Enterprises Ltd, Bnglore, Krntk, Indi Dr K.G.Kllur Eductionl Qulifiction: MBBS, DRM,MD Experience: Totl 26 yers. Worked s Lecturer nd Assistnt Professor of Nucler Medicine in vrious teching institutions in Indi. Currently working s 1. Hed of Nucler Medicine deprtment t Bnglore Institute of Oncology nd HCG in Bnglore from 1996 till dte. 2. Professor nd Hed of Nucler Crdiology division t Sri Jydev Institute of Crdiology Bnglore from Estblished Indi s first cgmp cyclotron nd PET trcer production fcility in the yer Currently doing bout 800 PET-CT scns per month nd pproximtely 200 Non FDG PET-CT scns per month. Estblished Nucler Medicine therpy nd currently doing bout 8-10 I-131 therpies for Crcinom Thyroid nd 5-6 PRRT for NET. Professionl ffilitions: 1. Member of SNM Indi nd SNMMI, EANM 2. Founder member ANMPI [Assocition of Nucler Medicine Physicins of Indi 3. Pst President of Southern Chpter of SNM Indi. 4. President ANMPI for the yer Are of interest: Rdiophrmcy" Recent Advnces in Sentinel Lymph Node Loclistion: Focus on SPECT/CT nd ICG-contining hybrid trcer Mondy AUDITORIUM 2 MASTER CLASS 3: SENTINEL NODE IMAGING: FUSION OF LIGHT AND SOUND SESSION Dr Rento Vldãs Olmos Senior Consultnt In Nucler Medicine Netherlnds Cncer Institute nd Leiden University Medicl Centre Rento Vldãs Olmos (MD, PhD) is Senior Consultnt in Nucler Medicine t the Netherlnds Cncer Institute Antoni vn Leeuwenhoek Hospitl, nd since October 2012 t the Leiden University Medicl Centre concerning Interventionl Moleculr Imging nd Nucler Medicine Section ctivities. Since 1993 he is involved in BNMS 43rd Annul Meeting 9

10 OVERSEAS INVITED SPEAKERS lymphtic mpping, rdioguided surgery nd the sentinel node procedure. He is founding member of the Interntionl Sentinel Node Society nd currently member of its bord. Involved in vrious projects concerning sentinel node identifiction using hybrid modlities for rdioctivity/fluorescence detection, he is lso one of the leders of n Eurostrs innovtion project concerning 3D rdioguided brest tumour excision nd surgicl nvigtion s well s of EU project concerning evlution of dedicted PET ring device for 18 F-FDG guided biopsy in brest cncer (MAMMOCARE). Rdioiodine therpy in thyroid cncer: Indin Perspective Mondy AUDITORIUM 2 MASTER CLASS 2: RADIONUCLIDE THERAPY SESSION Dr Prth Choudhury Director (Nucler Medicine) Rjiv Gndhi Cncer Institute & Reserch Centre Delhi Indi Grduted in1985. Diplomte Ntionl Bord (DNB) in Nucler Medicine in Totl experience of 22 yers in Clinicl Nucler Medicine (dignostic & therpeutic). Presently working s Director, Deprtment of Nucler medicine & PET-CT, t Rjiv Gndhi Cncer Institute nd reserch centre, Delhi, Indi. Joined the institution in Februry Clinicl Fellow in St.Vincent s Hospitl, University of New South Wles, Sydney Austrli in , PET-CT trining t Klinikum rechts der Isr Technische Universitt Munchen Germny in Recipient of UICC scholr wrds during the World Cncer Congress July 2006 Wshington DC & August 2010 Shenzen Chin, best poster wrd Lncet Medicl Forum 2007 Singpore nd Asi Oceni Distinguished Young Investigtors Awrd of the Jpnese Society of Nucler Medicine in Recipient of multiple IAEA trvel grnts. Lst one in October Hve lso been ssocited with IAEA s consultnt, course director, expert lecturer, chief scientific investigtor in co-ordinted reserch projects nd nominted prticipnts in multiple regionl trining courses. Member of the institutionl review bord (ethics committee), medicl udit committee, selection bord for consultnts nd rdition sfety committee. Served s the convener of the ethics committee from Member of Governing body of World Assocition of Rdiophrmceuticl & Moleculr Therpy (WARMTH). Invited externl expert (Nucler Medicine) in the ssessment bord for promotion / selection of scientists in Defence Reserch nd Development Orgnistion (DRDO) Government of Indi,Ministry of defence nd for selection of pool scientists in CSIR. Member of Editoril bord World Journl of Nucler Medicine & Indin Journl of Nucler Medicine. Member EANM & RSNA. Presented proferred ppers nd delivered invited tlks in ntionl nd interntionl meetings. Axillry Reverse Mpping - A concept towrds preventing lymphedem Mondy.10-. AUDITORIUM 2 MASTER CLASS 3: SENTINEL NODE IMAGING: FUSION OF LIGHT AND SOUND SESSION Prof Shnmug Sundrm P Clinicl Professor Amrit Institute of Medicl Sciences University, Cochin, Kerl, Indi Completed MBBS in 1989 from Mduri medicl college, Tmil Ndu, Indi, Diplom in Nucler medicine in 1995 from Rdition medicine centre, Tt Memoril hospitl, BARC Bomby, DNB (N Med) Diplomte of Ntionl bord & MNAMS in 1997 Jslok Hospitl, Mumbi. Initilly worked s Asst professor, Nucler medicine t S.V Institute of medicl sciences, Tirupti. Lter joined Amrit Institute of Medicl sciences (under Amrit vishw Vidypeethm University), Cochin, Kerl, Indi from 2000 till dte s Clinicl Professor in Nucler medicine & PET-CT. President elect (20-17) of Assocition of Nucler medicine physicins of Indi. Strted DNB (Diplomte of ntionl bord) Nucler medicine trining progrmme in our institute in Ours ws the first institute to be ccorded MD Nucler medicine progrmme under Medicl council of Indi in Attended fellowship progrmmes in PET-CT imging t Ktherine Hospitl, Stuttgrt, Germny nd lso t Peter Mc Cllum cncer Pge 10 BNMS 43rd Annul Meeting

11 OVERSEAS INVITED SPEAKERS centre, Melbourne, Austrli. I m n ctive member of Society of Nucler medicine Indi, ANMPI, nd lso of Europen society of Nucler medicine, nd Americn society of nucler crdiology. Achievements: Recipient of young investigtor wrds from Indo Americn society of Nucler medicine IASNM in 2002 in Los Angeles, USA, Multiple Trvel grnt wrds from Europen society of Crdiology 2005, 2007 & 2013, ARCCNM 2005, WFNMB t Seoul, South Kore 2006 nd IAEA 2007, I hve 92 ntionl & interntionl publictions to my credit prt from contributing to books in Nucler medicine. Slivgrm - A sensitive investigtion in the evlution of ntegrde spirtion Mondy SYNDICATE 1&2 BONE SPECT & ENDOCRINE HEPATOBILIARY SESSION DR S. Pdm Clinicl Professor Amrit Institute of Medicl Sciences Univerity, Cochin, Kerl, Indi Completed medicl grdution (MBBS) in 1990 from SCB Medicl College, Cuttck, Odish, Indi nd postgrdution in Nucler medicine in 1995 from Rdition medicine centre, Tt Memoril hospitl, BARC, Bomby, Indi. Initilly worked t Nucler medicine centres in Port trust hospitl, Mumbi nd S.V Institute of medicl sciences, Tirupti. Joined Amrit Institute of Medicl sciences (under Amrit vishw Vidypeethm University), Cochin, Kerl, Indi in the yer 2000 nd presently serving s Clinicl Professor in Deprtment of Nucler medicine & PET-CT in the sme institute. Pst President of Society of Nucler medicine Indi, south chpter Techer nd guide to DNB (Nucler med) nd MD Nucler medicine students. Published 89 scientific ppers, review rticles, nd chpters in books on Nucler medicine. Recipient of Arcot Gjrj Best pper wrd from Society of Nucler medicine Indi south chpter in the yer Also received multiple young investigtor nd trvel grnt wrds from interntionl societies like Europen society of Crdiology (ICNC), Asin Regionl Coop Council on Nucler Medicine (ARCCNM), Interntionl Atomic Energy Agency (IAEA) nd World Federtion of Nucler medicine & biology (WFNMB). My extrcurriculr ctivities: clssicl Odissi dncer, completed postgrdution (MA) in Odissi dnce from Kl viks Kendr, Cuttck, Odish Recent Advnces in Instrumenttion & Techniques Mondy AUDITORIUM 2 MASTER CLASS 3: SENTINEL NODE IMAGING: FUSION OF LIGHT AND SOUND SESSION Dr Thoms Wendler CTO & VP of Medicl Affirs SurgicEye GmbH Dr. Thoms Wendler is CTO & VP of Medicl Affirs nd one of the co-founders of SurgicEye GmbH. Dr. Wendler studied Electronic Engineering t Universidd Tecnic Federico Snt Mri (UTFSM) in Vlpri so, Chile. For his consistently excellent results, he received vrious ccoldes nd Best Student of the Yer wrds. He completed his studies in the field of biomedicl engineering t Technische Universitt Munchen (TUM) in Munich, Germny with the DAAD Best Student 2007 Awrd. In 2010 he closed with highest distinction his Ph.D. in medicl imging t TUM. Before his mngement ctivities t SurgicEye GmbH Dr. Wendler ws responsible for the reserch field of Moleculr Imging t the Deprtment for Computer Aided Medicl Procedures t TUM. He hd lso secondry ppointment t the Nucler Medicine Deprtment t Klinikum rechts der Isr where he ws responsible for the instllment of the centrl interdisciplinry reserch lbortory. In 2006 he introduced nd developed the concept of freehnd moleculr imging opening new wys in rdio-guided surgery nd intervention. BNMS 43rd Annul Meeting Pge 11

12 SOCIAL EVENTS BRIGHTON 20 BNMS Annul Awrds Dinner Ech yer the BNMS gthers to celebrte outstnding chievements in the contribution to the field of science nd prctice of nucler medicine in the United Kingdom. Now in its 43rd yer, BNMS delegtes re invited to enjoy dinner nd dnce in the Pgnini Room on the Tuesdy 28th April t Old Ship Hotel, Brighton from 7.pm till lte. Entertinment will be provided by The Abductors. Tickets re 40 ech. Plese enquire t the registrtion desk for vilbility. BNMS Fun Run 20 With such gret response received from pst meetings, the BNMS will be orgnising nother 3K Chrity Fun Run supporting Autism Sussex. Mke your own tem from your hospitl deprtment or run solo nd join us on the Brighton brod wlk on Tuesdy 28th April 7. m All re encourged to tke prt or cheer on the contenders t the finish line. Trophy for 1st plce will be wrded on Tuesdy. BNMS Clinicl Prctitioner s Group 25th Anniversry Celebrtion nd President's Reception The BNMS Clinicl Prctitioner s Group of Rdiogrphers nd Technologists will be celebrting its 25th nniversry t the BNMS Annul Spring Meeting in Brighton. To commemorte this importnt lndmrk, ll Clinicl Prctitioners re invited to pply for free plce to our proffered ppers nd invited spekers session on Mondy 27th April t 3pm. This will be followed by celebrtory cke t the President s Reception. The celebrtions will continue with socil gthering t the 'Fortune of Wr' pub from 8.00pm. To register for socil gthering plese contct Ktherine.Dy@bsuh.nhs.uk 12 BNMS 43rd Annul Meeting

13 PLENARY SESSIONS MONDAY 27TH APRIL AUDITORIUM 2 INAUGURATION OF THE BNMS 43RD ANNUAL SPRING MEETING Dr. Alp Notghi, Birminghm City Hospitl, BNMS President Dr. Brin Neilly, Glsgow Royl Infirmry, Immedite Pst President TUESDAY 28TH APRIL AUDITORIUM 2 ANNUAL LECTURE The Evolving Role of Clinicl Moleculr Imging in Multi-Disciplinry Cncer Cre Professor Homer A. Mcpinlc Jmes E. Anderson Distinguished Professor & Chir, Deprtment of Nucler Medicine University of Texs M.D. Anderson Cncer Center Houston, Texs WEDNESDAY 29TH APRIL AUDITORIUM AWARDS CEREMONY WEDNESDAY 29TH APRIL AUDITORIUM HIGHLIGHTS OF THE BNMS 43RD ANNUAL SPRING MEETING Dr. Brin Neilly, Glsgow Royl Infirmry, Immedite Pst President BNMS 43rd Annul Meeting 13

14 AT A GLANCE PROGRAMME SUNDAY 26TH APRIL BOOTCAMP CONVENTIONAL NUCLEAR MEDICINE & PET/CT: BEST PRACTICE CONSENSUS & HOW THE EXPERTS DO IT? Syndicte 3 Syndicte PET/CT IN ONCOLOGY PET/CT IN ONCOLOGY REGISTRATION IN FOYER AND COMPLIMENTARY BUFFET LUNCH IN SYNDICATE CONVENTIONAL NUCLEAR MEDICINE BEST PRACTICE CONSENSUS FOR CLINICAL PRACTITIONERS/ TECHNOLOGISTS.00-. Te & Coffee in Exhibition Hll Te & Coffee in Exhibition Hll PRE- REGISTRATION AND WELCOME RECEPTION IN FOYER Meeting Room MOLECULAR RADIOTHERAPY TRAINING PRE-REGISTRATION REQUIRED Pge 14 BNMS 43rd Annul Meeting

15 AT A GLANCE PROGRAMME MONDAY 27TH APRIL AUDITORIUM 2 SYNDICATE MASTER CLASS 1: PET/MRI MASTER CLASS 2: RADIONUCLIDE THERAPY MASTER CLASS 3: SENTINEL NODE IMAGING: FUSION OF LIGHT AND SOUND Te & Coffee in the Exhibition Hll NUCLEAR MEDICINE: THE CHANGING LANDSCAPE ABSTRACTS PET/CT & PET/MRI: ABSTRACTS PROFERRED PAPERS PHYSICS: PROFFERED PAPERS AMYVID (FLORBETAPIR 18F) PET IMAGING READER TRAINING, PRE-REGISTRATION REQUIRED Inugurtion Dr. Alp Notghi & Dr Brin Neilly Te & Coffee in the Exhibition Hll Lunch & Meet Industry in the Exhibition Hll Moderted Poster session P1 - P52 SYNDICATE 3 SYNDICATE PHYSICS: INVITED REVIEW & PROFFERED PAPERS CARDIOLOGY: INVITED REVIEW & PROFFERED PAPERS ONCOLOGY: INVITED REVIEW & PROFFERED PAPERS Te & Coffee in the Exhibition Hll BONE SPECT & ENDOCRINE HEPATOBILIARY CLINICAL PRACTITIONERS CONTINUING EDUCATION SERIES CLINICAL PRACTITIONERS CONTINUING EDUCATION SERIES 2: MEDICS FORUM - DISCUSS 'HOT TOPICS' CLINICAL PRACTIONEERS: INVITED TALKS & PROFFERED PAPERS' Te & Coffee in the Exhibition Hll CLINICAL PRACTIONEERS: PROFFERED PAPERS BNMS 43rd Annul Meeting Pge

16 AT A GLANCE PROGRAMME TUESDAY 28TH APRIL AUDITORIUM 2 SYNDICATE MASTERCLASS IV: LUNG CANCER MASTERCLASS V: LYMPHOMA ANNUAL LECTURE "THE EVOLVING ROLE OF CLINICAL MOLECULAR IMAGING IN MULTI-DISCIPLINARY CANCER CARE": PROFESSOR HOMER MACAPINLAC, MD ANDERSON CANCER CENTRE, THE UNIVERSITY OF TEXAS ANNUAL LECTURE SESSION - VIDEO PRESENTATIONS AND INVITED TALK Te & Coffee in the Exhibition Hll BNMS ANNUAL GENERAL MEETING RADIOPHARMACY: ABSTRACTS MOLYBDENUM SUPPLY ABSTRACTS RADIOPHARMACY: PROFFERED PAPERS.-16. TRAINEES FORUM - DEENA NERIMAN Te & Coffee in the Exhibition Hll Te & Coffee in the Exhibition Hll Lunch & Meet Industry in the Exhibition Hll Moderted Poster session P53 - P116 SYNDICATE 3 SYNDICATE SERVICE MANAGEMENT: INVITED REVIEW & PROFFERED PAPERS NEUROLOGY: INVITED REVIEW & PROFFERED PAPERS PAEDIATRIC & MANAGEMENT: INVITED REVIEW & PROFFERED PAPERS CLINICAL PRACTITIONERS: CONTINUING EDUCATION SERIES CLINICAL PRACTITIONERS CONTINUING EDUCATION SERIES Te & Coffee in the Exhibition Hll Te & Coffee in the Exhibition Hll Te & Coffee in the Exhibition Hll PET/CT CASE REVIEW: "DEALING WITH THE CLINICAL CHAMELEON" Pge 16 BNMS 43rd Annul Meeting

17 AT A GLANCE PROGRAMME WEDNESDAY 29TH APRIL AUDITORIUM 2 SYNDICATE YOUNG INVESTIGATORS PRIZE Te & Coffee NUCLEAR MEDICINE: MISCELLANEOUS INVITED SPEAKERS RADIONUCLIDE THERAPY PROFFERED PAPERS Te & Coffee Te & Coffee AWARDS CEREMONY HIGHLIGHTS LECTURE DR BRIAN NEILLY Lunch nd Close of Meeting SYNDICATE NUCLEAR MEDICINE: MISCELLANEOUS PROFFERED PAPERS NUCLEAR MEDICINE COMMUNICATIONS FREE ONLINE ACCESS TO THE MAY ISSUE FOR ALL DELEGATES All delegtes cn ccess the My edition of NMC contining the bstrct booklet for BNMS Brighton 20 vi the website: or vi the QR code. NMC - A monthly rpid communictions journl publishing reserch nd clinicl work in ll res of nucler medicine for n interntionl redership. In ddition to refered ppers, the journl fetures frnkly written editorils, topicl reviews, book reviews nd reporting of interntionl conferences. NMC is the officil Journl of the British Nucler Medicine Society. Full ccess to the online version of Nucler Medicine Communictions is included in the BNMS membership fee. NMC is now vilble vi n pp for ipd for ll members. Join the BNMS for full ccess to NMC. Find out more from the BNMS registrtion desk BNMS 43rd Annul Meeting Pge 17

18 FULL PROGRAMME BOOT CAMP SUNDAY 26TH APRIL BOOT CAMP 20 Conventionl Nucler Medicine & PET/CT: Best Consensus & How the experts do it. Syndicte REGISTRATION IN FOYER AND COMPLIMENTARY BUFFET LUNCH IN SYNDICATE PET/CT IN ONCOLOGY 1 Modertors Dr R Syed & Dr A Scrsbrook Overview of PET/CT Applictions in Gynecologicl Mlignncies. Dr Tr Brwick Imperil College Helthcre NHS Trust Overview of Neuro-Oncology PET/CT/MRI Applictions Dr Frncesco Frioli University College London Hospitls Overview of PET/CT in mngement of Brest Cncer. Dr Ngesh Ngbhushn Overview of PET/CT Applictions in Melnom. Dr Andrew Scrsbrook Leeds Teching Hospitls NHS Trust.00-. Te & Coffee in Syndicte PET/CT IN ONCOLOGY 2 Modertors Dr R Syed & Dr A Scrsbrook Urgent CT Findings in the Thorx, bdomen nd Pelvis: Wht re they nd how to communicte. Dr Tom Lynch Northern Irelnd Cncer Centre Belfst Wht to do bout unexpected findings on PET-CT scn. Dr Wilup Wong Mount Vernon Hospitl Role of PET/CT in Dementi Dr Zrni Win Imperil College NHS Trust PET/CT Protocols: Ptient Pthwy: Dr Teres Szyszko PET Imging Centre t St Thoms Hospitl London Structured PET/CT reporting: Chllenges & solutions. Dr Simon Hughes Nottinghm University Hospitls NHS Trust PRE- REGISTRATION & WELCOME RECEPTION FOYER Syndicte REGISTRATION IN FOYER AND COMPLIMENTARY BUFFET LUNCH IN SYNDICATE CONVENTIONAL NUCLEAR MEDICINE: BEST PRACTICE CONSENSUS FOR CLINICAL PRACTIONERS/ TECHNOLOGISTS Modertors Lloyd Rowling & Smer Bngsh Imging the Brin: A Guide for Technologists Dr Gregory Shbo Est Kent Hospitls University NHS Foundtion Trust Imging Peditric ptients: A Guide for Technologists. Dr Lorenzo Bissoni Gret Ormond Street Hospitl for Children NHS Foundtion Trust Crdic SPECT reconstruction: A Guide for Technologists. Speker to be confirmed Ptient preprtion for PET/CT: Chllenges & solutions. Joemon John Clinicl PET centre, Guys & St Thoms NHS Hospitl.00-. Te & Coffee Meeting Room MOLECULAR RADIOTHERAPY TRAINING PREREGISTRATION REQUIRED Mtthew Guy University Hospitl Southmpton Session 1 l Physicl requirements of rdiophrmceuticls used for MRT nd their biokinetics l Approprite selection nd opertion of rdition monitors nd detectors l Therpy Room Design Te & Coffee Pge 18 BNMS 43rd Annul Meeting

19 FULL PROGRAMME BOOT CAMP Session 2 l Clinicl ppropriteness of MRT requests (mjor types, supported by NICE, CDF, evidence...) l Prior Ptient-Specific Risk Assessment nd Dischrge Guidnce, including worked exmples l WB monitoring nd dosimetry theory, including ptient enggement Te & Coffee Session 3 l WB dose clcultion workshop including cse studies looking t impct of dt selection / qulity, geometry nd trcer therpy conversion clcultions BNMS 43rd Annul Meeting Pge 19

20 FULL PROGRAMME MONDAY 27TH APRIL AUDITORIUM INAUGURATION Dr. Alp Notghi & Dr Brin Neilly MASTER CLASS 1: PET/MRI Chirs Dr Brin Hutton & Dr. Wi-Lup Wong PET/MRI Bsics & Instrumenttion. Ann Brnes University College London Hospitls NHS Foundtion Trust PET/MRI in Oncology: Impct on prctice, Dr Rizwn Syed University College London Hospitls NHS Foundtion Trust Role of PET/MRI: n Emerging Technology in non-oncologicl disese. Dr Frncesco Frioli University College London Hospitls NHS Foundtion Trust Te & Coffee in the Exhibition Hll MASTER CLASS 2: RADIONUCLIDE THERAPY Chirs Dr. Yong Du nd Prof Jsn Mihilovic Mngement of Benign Thyroid disese: Stte-of-rt Dr Mrk Vnderpump Royl Free London NHS Foundtion Trust Rdioiodine therpy in thyroid cncer: Indin Perspective Dr Prth Chudry Rjiv Gndhi Cncer Institute & Reserch Centre Delhi Indi Chnging Prctice: Rdionuclide therpy in NET Dr Shunk Nvlkissoor Royl Free London NHS Foundtion Trust Rdionuclide therpy in bone pllition: Where re we? Prof Vl Lewington King's College London Lunch & Meet Industry in the Exhibition Hll Moderted Poster Session MASTER CLASS 3: SENTINEL NODE IMAGING: FUSION OF LIGHT AND SOUND Chirs Dr Rosemry Alln & Prof Drzen Huic Rdionuclide Sentinel Lymph Node Imging: An Overview Dr Alp Notghi, City Hospitl Birminghm, Sndwell nd West Birminghm Hospitls NHS Trust Sentinel Lymph node biopsy in Hed & Neck cncer: Now we re Tlking Prof Mrk McGurk Guy's nd St Thoms' NHS Foundtion Trust SNI node excision in Mlignnt Melnom: Surgeons Perspective Beyond Hot Spots Mrs Jenny Geh Guy's nd St Thoms' NHS foundtion Trusts.10-. Axillry Reverse Mpping - A concept towrds preventing lymphedem Dr P Shnmug Sundrm Amrit Institute of Medicl Sciences University, Cochin, Kerl, Indi Recent Advnces in Sentinel Lymph Node Loclistion: Focus on SPECT/CT nd ICG Prof Rento Vldes Netherlnds Cncer Institute nd Leiden University Medicl Centre Recent Advnces in Instrumenttion & Techniques Dr Thoms Wendler, SurgicEye GmbH Te & Coffee in the Exhibition Hll NUCLEAR MEDICINE: THE CHANGING LANDSCAPE Chirs Dr Si Hn & Dr. Vineet Prksh ARSAC Updte: Expected Chnges Dr Steve Ebdon-Jckson Public Helth Englnd The 2014 Revised Specility Trining Curriculum Dr Prvulovich 1, Dr Brin Neilly 2, Dr J Buscombe 3, University College London Hospitls NHS Foundtion Trust 1 Glsgow Royl Infirmry 2 Cmbridge University Hospitls PRESIDENT'S RECEPTION - EXHIBITION HALL SYNDICATE INAUGURATION Dr. Alp Notghi & Dr Brin Neilly PROFFERED PAPERS PET/CT & PET/MRI Chir Dr Ngesh Ngbhushn F-DOPA PET-MRI in Peditric Congenitl Hyperinsulinism: Comprison to PET-CT M Gvr 1, J Connelly 1, S Michopoulou 1, R Endozo 1, K Hussin 2, R Syed 1, L Menezes 1, J Bomnji 1, 1 Institute of Nucler Medicine, University College London Hospitl NHS FT, London, UK, 2 Clinicl nd Moleculr Genetics Unit, The Developmentl Endocrinology Reserch Group, Institute of Child Helth, University College London nd Gret Ormond Street Hospitl for Children, NHS FT, London, UK Pge 20 BNMS 43rd Annul Meeting

21 FULL PROGRAMME MONDAY FDG-PET-CT Sheds New Light in the Clinicl Mngement of Richter's Trnsformtion from Chronic Lymphocytic Leukemi (CLL) Y Du, The Royl Mrsden NHS Foundtion trust, Sutton, UK Eight Yers of Experience with 68 G-DOTATATE PET-CT Imging in Neuroendocrine Tumours E. Skour 1, E. Pngiotidis 1, M. Al-Hrbi 1, I. Kyni 1, R. Syed 1, M.E. Cplin 2 nd J. Bomnji 1, 1 Nucler Medicine Deprtment, University College Hospitl nd 2 Neuroendocrine Tumour Unit, Royl Free Hospitl, London, UK Impct of Dietry Crbohydrte Restriction Prior to 18 F-FDG PET-CT for Suspected Crdic Implntble Electronic Device (CIED) Infection nd Endocrditis. JM Jmes 1, M Memmott 1, F Ahmed 2, 1 Nucler Medicine Centre, Centrl Mnchester NHS Foundtion Trust, Mnchester, UK, 2 Deprtment of Crdiology, Centrl Mnchester NHS Foundtion Trust, Mnchester, UK Segmenttion Bsed Attenution Correction for PET/MR: Artifcts nd Pitflls S Michopoulou, A Brnes, S Wn, D Brown, S Burns, JC Dickson, Insitute of Nucler Medicine, University College London Hospitls, London, UK The Clinicl Vlue of 18 F-FDG PET-CT in the Dignosis of Lrge-Vessel Vsculitis: A District Generl Hospitl Experience B Clrke, R Mliy, H Linklter, S Ptel, A Prthipun, Epsom & St Helier University Hospitls NHS Trust, Surrey, UK Benefit of Wholebody Quntifiction of 18 F-Fluoride PET Imges Over Trget Lesion Anlysis Alone For Prognostiction For Ptients With Bone Metstses From Metsttic Prostte Cncer. B Tylor 1,2, S Hughes 1, M Siddique 2, J Joemon 1, I Fogelmn 1, S Chowdhury 1, V Goh 2,1, GJ Cook 2,1, 1 Guy's & St Thoms' NHS Foundtion Trust, London, UK, 2 King's College London, London, UK Combining A weight-bsed Dosing Scheme With Time-of-Flight For Further Reductions In Ptient nd Stff FDG Doses IS Armstrong, JM Jmes, S Muthu, Centrl Mnchester University Hospitls, Mnchester, UK Te & Coffee in the Exhibition Hll PHYSICS: PROFFERED PAPERS Chirs Prof Aln Perkins nd Mri Burniston A Method to Identify Periods of Miniml Ptient Motion in Florbetpir [ 18 F] (Amyvid) PET-CT Scns D Fkhry-Drin 1, R T Medes 1, L Perry 1, B Willims 2, Z Win 2, K S Nijrn 1 1 Rdiologicl Sciences Unit, Imperil College Helthcre NHS Trust, London, UK, 2 Nucler Medicine, Imperil College Helthcre NHS Trust, London, UK Poisson Resmpling Softwre Vlidtion G Jmes, J O'Brien, WH Thomson, City Hospitl, Birminghm, UK Rdition Sfety in Brest Cncer Surgery: Intr-Opertive Cerenkov Luminescence Imging. C Sibley-Allen 1 *, MR Grootendorst 2 *, A Jones 1, SM Gould 1, P Crosdle 1, E Lee 1, S Allen 1, A Purushothm 2, 1 Guy's nd St Thoms' NHS Foundtion Trust, London, UK, 2 King's College London, London, UK * =Joint first Author The Effect of Attenution nd Sctter Correction In Brin Perfusion SPECT Imging For Dementi R Gillen 1, M J Firbnk 2,3, J Lloyd 2, J T O'Brien 3,4, 1 South of Tyne Medicl Physics Deprtment, City Hospitls Sunderlnd, Tyne nd wer, UK, 2 Nucler Medicine Deprtment, Newcstle upon Tyne Hospitls NHS Foundtion Trust, Newcstle upon Tyne, UK, 3 Institute of Neuroscience, Cmpus for Ageing nd Vitlity, Newcstle University, Newcstle upon Tyne, UK, 4 Deprtment of Psychitry, University of Cmbridge School of Clinicl Medicine, Cmbridge Biomedicl Cmpus, Cmbridge, UK SeHCAT Room vs. Ptient Bckground: Which is better? G Jmes, J O'Brien, WH Thomson, City Hospitl, Birminghm, UK Optimistion of 90Y post-sirt PET Imging Using Novel PET Reconstruction Algorithm LM Rowley 1, DR McGown 1,2, KM Brdley 1, A Hllm 1, 1 Oxford University Hospitls NHS Trust, Oxford, UK, 2 University of Oxford, Oxford, UK A Comprison of Lung Tumour Motion s Determined by 4 DCT nd Dt Driven Gting of PET-CT S Woods, P Julyn, The Christie NHS Foundtion Trust, Mnchester, UK Clinicl Scientist Forum Lunch & Meet Industry in the Exhibition Hll Moderted Poster session AMYVID (FLORBETAPIR 18 F) PET IMAGING READER TRAINING Te & Coffee Dr Simon Hughes, Consultnt in Rdiology nd Nucler Medicine, Nottinghm University Hospitl Eli Lilly nd Compny LTD hve sponsored the content of this session AMYVID (FLORBETAPIR 18 F) PET IMAGING READER TRAINING CONTINUED PRESIDENT'S RECEPTION - EXHIBITION HALL BNMS 43rd Annul Meeting Pge 21

22 FULL PROGRAMME MONDAY SYNDICATE INAUGURATION Dr. Alp Notghi & Dr Brin Neilly PHYSICS : INVITED REVIEW & PROFFERED PAPERS Chirs S Allen & P Hinton Stremlining Administered Activity, Scnning Time for PET with TOF systems. In Armstrong Centrl Mnchester University Hospitls Optimistion of Myocrdil Perfusion SPECT Using LEGP Collimtors nd Resolution Recovery IS Armstrong, KJ Sint, Centrl Mnchester University Hospitls, Mnchester, UK rd Plce Student Prize 2. Role of Fctor Anlysis in the Automtic Evlution of Rdionuclide Imges MJ Rowlndson, DJ Towey, KS Nijrn, Imperil College Helthcre NHS Trust, London, UK Comprison of 99m Tc-MAA nd 90 Y-Microsphere Distributions A.J Crig 1,2, I Murry 1, A.M Denis-Bcelr 2, J Ger 1, N Khn 3, A Menhout 3, B Rojs Fisher 4, L Hossen 4, G Flux 1,2, 1 Royl Mrsden NHSFT, Surrey, UK, 2 Institute of Cncer Reserch, Surrey, UK, 3 Chelse & Westminster NHSFT, London, UK, 4 Royl Brompton NHSFT, London, UK K-Mens Clustering Algorithm for Delinetion of The Liver For 90Y microsphere Therpy Dosimetry A.J Crig 1,2, I Murry 1, A.M Denis-Bcelr 2, J Ger 1, N Khn 3, A Menhout 3, B Rojs Fisher 4, L Hossen 4, G Flux 1,2, 1 Royl Mrsden NHSFT, Surrey, UK, 2 Institute of Cncer Reserch, Surrey, UK, 3 Chelse & Westminster NHSFT, London, UK, 4 Royl Brompton NHSFT, London, UK Does Collimtor Response Modelling (CRM) of 123 I SPECT dt cquired with Low Energy High Resolution (LEHR) Collimtors Improve Uniformity? CM Brown 1,2, G Gillen 2, MF Dempsey 2, A Nicol 3, 1 University of Glsgow, Glsgow, UK, 2 Grtnvel Generl Hospitl, Glsgow, UK, 3 Southern Generl Hospitl, Glsgow, UK Te & Coffee in the Exhibition Hll CARDIOLOGY : INVITED REVIEW & PROFFERED PAPERS Chirs Dr Kshm Wechlekr & Dr Prthibn Arumugm IRb Crdic PET imging: Hurdles of defending the service. Dr Prthibn Arumugm, Centrl Mnchester University Hospitls Nucler Crdiology: The next decde. Prof Richrd Underwood Imperil College, London Reducing 99m Tc usge in Myocrdil Perfusion SPECT in Preprtion for Future Isotope Shortges IS Armstrong, KJ Sint, CM tonge, P Arumugm, Centrl Mnchester University Hospitls, Mnchester, UK Is erly exercise 99m Tc-Sestmibi Myocrdil Perfusion Scintigrphy Fesible? E Ppdopoulos, V Schpekidis, GA Wright, AC Tweddel, Hull nd Est Yorkshire Hospitls NHS Trust, Cottinghm, Est Yorkshire, UK Perfusion-corrected 99m Tc-MIBI for the Identifiction of Crdic Mitochondril toxicity Z. Sfee, P.J Blower, R. Southworth, Kings College London, London, UK Trunction Artefcts in Computed Tomogrphy (CT) Attenution Correction (AC) for Myocrdil Perfusion Studies (MPS) J O'Brien, A Notghi, GD Jmes, WH Thomson, Sndwell & West Birminghm Hospitls NHS Trust, West Midlnds, UK Modelling Locl Acute 7-Dy Nucler Crdiology Service Demonstrtes Finncil Benefit In Mnging Acute Coronry Syndromes (ACS) In A UK NHS Trust K Dy, N Singh, S Dizdrevic, Brighton nd Sussex University Hospitls Trust, Brighton, Est Sussex, UK Lunch & Meet Industry in the Exhibition Hll Moderted Poster session ONCOLOGY: INVITED REVIEW & PROFFERED PAPERS Chirs Dr N Khlid Nwz & Dr Alexis Corrign Tumour Heterogenity: Science & Clinicl Appliction Prof Gry Cook King's College London FDG PET-CT Imging of Nodl Metstses Distribution In Nsophryngel Crcinom (NPC) A Al Tmimi 1, S Zheer 3, S Osmny 2, 1 Msschusetts Generl Hospitl/Hrvrd Medicl School, Boston, USA, 2 Rdlink crdic nd PET Imging, Singpore, Singpore, 3 Singpore Generl hospitl, Singpore, Singpore Heterogeneity of Tretment Response In Skeletl Metstses From Brest Cncer in 18 F-fluoride nd 18 F-FDG PET. GJ Cook 1, BP Tylor 1, J Glendenning 2, M Siddique 1, J John 1, V Goh 1, J Mnsi 2, M Hrries 2, I Fogelmn 1, 1 Kings College London, London, UK, 2 Guys & St Thoms' NHSFT, London, UK Pge 22 BNMS 43rd Annul Meeting

23 FULL PROGRAMME MONDAY m Tc-Sestmibi Moleculr Brest Imging Guided Stereotctic Needle Biopsy of Rdiologiclly Occult Brest Lesions LM Pereir Aris-Boud 1,2, F Smit 1,2, P Neijenhuis 1, LMH Wijers 1, AF vn der Hoeven 1, K Hofkes-Fillekes 1, A Zeillemker 1, RA Vldes Olmos 2, 1 Rijnlnd Hospitl, Leiderdorp, The Netherlnds, 2 Leiden University Medicl Center, Leiden, The Netherlnds Predicting Neodjuvnt Chemotherpy Response In Oesophgel Cncer From Pretretment 18 F-FDG PET Using A Deep Neurl Network Model. GJ Cook 1, PP Ypsilntis 1, HM Sohn 1, M Siddique 1, A Dvies 2, V Goh 1, G Montn 1 1 Kings College London, London, UK, 2 Guys & St Thoms' NHSFT, London, UK.18.. Mngement Decision: Role of 68 G-DOTATATE PET-CT imging in ptients' with Neuroendocrine Tumours E Skour 1, E Pngiotidis 1, M Al-Hrbi 1, I Kyni 1, R Syed 1, ME Cplin 2, J Bomnji 1 1 Nucler Medicine Deprtment, University College Hospitl, London, UK, 2 Neuroendocrine Tumour Unit, Royl Free Hospitl, London, UK Te & Coffee in the Exhibition Hll BONE SPECT & ENDOCRINE HEPATOBILIARY Chirs Dr Rghuveer Venknngri & Dr N Mulhollnd Slivgrm -A sensitive investigtion in the evlution of ntegrde spirtion Dr S Pdm Amrit Institute of Medicl Sciences University, Cochin, Kerl, Indi Gstric Emptying Studies, Science nd Prctice Prof Aln Perkins Nottinghm University Hospitls NHS Trust, Nottinghm The Role of 99m Tc MDP SPECT-CT of the Foot & Ankle B Updhyy, KE Low, Z Sd, J Buscombe, Cmbridge University Hospitls, Cmbridge, UK The Additionl Vlue of 18 F Fluoride PET-CT Bone Scns Over Plnr Bone Scintigrphy Using 99m Tc MDP nd Its Impct On Ptient Mngement In Brest Cncer Ptients R K Kulshresth 1,2, S Vinjmuri 2,3, P Hogg 3, A Englnd 3, 1 Centrl Mnchester University Teching Hospitls NHS Foundtion Trust, Mnchester, UK, 2 Royl Liverpool University Teching Hospitls NHS Foundtion Trust, Liverpool, UK, 3 University of Slford, Slford, UK A Comprison of Different Anlysis Techniques for Temporomndibulr Joint (TMJ) Bone Scns A-M Tutty, AA Bolster, G Ainslie-McLren, C Pterson, H Wllce, J Wright, Dept. of Nucler Medicine, Glsgow Royl Infirmry, Glsgow, UK Clinicl Evlution of Xspect Reconstruction For 99m Tc Diphosphonte SPECT Bone Imging. L Vss, I Wllner, A Irwin, St George's Helthcre NHS Trust, London, UK SPECT-CT In Ptients With Symptomtic Knee Arthroplsty Do Rdiologicl Reports Correlte With Orthopedic Clinicl nd Surgicl Findings? R Jmes, S Redmn, R Grhm, Royl United Hospitl NHS Foundtion Trust, Bth, UK Single Photon Emission Computed tomogrphy (SPECT)-CT Imging Loclistion of Prthyroid Adenoms Preopertively S Toms Hernndez, J O'Brien, A Notghi, M Pndit, City Hospitl, Birminghm, West Midlnds, UK Dul Isotope Subtrction SPECT-CT in the Dignosis of Primry Hyperprthyroidism A-M Tutty 1, AA Bolster 1, JB Neilly 1, FW Poon 1, D Colville 1, J Shnd 2, S Hn 1, 1 Dept. of Nucler Medicine, Glsgow Royl Infirmry, Glsgow, UK, 2 Dept. of Nucler Medicine, Stobhill Hospitl, Glsgow, UK PRESIDENT'S RECEPTION - EXHIBITION HALL SYNDICATE INAUGURATION Dr. Alp Notghi & Dr Brin Neilly CLINICAL PRACTITIONERS CONTINUING EDUCATION SERIES 1 Chirs Lloyd Rowling & Ktherine Dy Sentinel lymph node dissection in the Operting thetre: Surgicl chllenges, Dr Clre Schilling Guy's Hospitl, King's College London Nucler Medicine Imging of Heptobiliry System Dr Nicol Mulhollnd King's College Hospitl Nucler Medicine nd Oncology, Dr Frncis Sundrm University Hospitl Southmpton Te & Coffee in the Exhibition Hll CLINICAL PRACTITIONERS CONTINUING EDUCATION SERIES 2 : Chirs S Johns & Lloyd Rowling CT Workshop for Nucler Medicine Technologists Prt 1- ( hed/ neck & thorx) Red with the Experts (Physics, rdiophrmcy, rdition protection): Interctive Quiz BNMS 43rd Annul Meeting Pge 23

24 FULL PROGRAMME MONDAY Lunch & Meet Industry in the Exhibition Hll Moderted Poster session CLINICAL PRACTITIONERS: INVITED TALKS & PROFFERED PAPERS Chir Lloyd Rowling & Ktherine Dy CT Competencies for NM Prctitioners Simon King, University of West of Englnd, SCoR Nucler yers of the BNMS Clinicl Prctitioner Group Spekers to be confirmed Technicl Errors Associted with Incorrect Renogrm Processing nd How to Avoid these. P Josephs, I Mteo-Vito, S Nvlkissoor, Royl Free London NHS Foundtion Trust, London, UK Nucler Medicine Technologists Eduction nd Trining in Europe A. Mtos, R. Mss, T. Vz, F. Lucen, Escol Superior de Tecnologis d Súde de Lisbo, Lisbon, Portugl Te & Coffee in the Exhibition Hll CLINICAL PRACTIONEERS: PROFFERED PAPERS Chirs Sndr Johns & Lloyd Rowling Simultneous PET-MRI: Chllenges for Technologists nd Rdiogrphers J Stirling, J John, L Shlby, V Goh, GJ Cook, P Ptel, Kings College London, London, UK Usefulness of Non-Attenution Correction Imges In Suspected Crdic Implntble Electronic Device Relted Infection C. Abreu 1, J. O'Doherty 1, A. Corrign 2, S. Brrington 1, J. John 1, A. Jcob 1, S. Pereir 1, L. Alves 1, R. Cbrl 1, 1 PET Imging Centre, Division of Imging Sciences nd Biomedicl Engineering, King s College London, King s Helth Prtners, St Thoms Hospitl, London, UK, 2 Deprtment of Rdiology, Midstone Hospitl, Midstone nd Tunbridge wells NHS Trust, Kent, UK Are Rdition Protection Restrictions Required For Ptients Following 64 Cu-ATSM PET Studies? S. Pereir, E. Woods, J. John, A. Jcob, C. Abreu, L. Alves, R. Cbrl, Y. Suh, L. Pike PET Imging Centre, St Thoms' Hospitl, Division of Imging Sciences nd Biomedicl Engineering, King's College London, King's Helth Prtners, London, UK Is A Blunted' Hert Rte Response (HRR%) to Regdenoson Stress An Adverse Prognostic Indictor For Future Crdic Events In Ptients With A Low Risk' Myocrdil Perfusion Study (MPS)? AS Reimo, N Singh, M Aplin, A Clrke, A Hosur, K Dy, S Dizdrevic, Brighton nd Sussex University Hospitls NHS Trust, Brighton, Sussex, UK The Influence of Quntifiction on SPECT 123 Ioflupne Reporting A Mtos, M Jessop, AM Peters, N Singh, A Hosur, V Rmn, G Kermid, M Aplin, S Dizdrevic, Nucler Medicine, Deprtment of Imging, Brighton nd Sussex University Hospitls NHS Trust, Brighton, UK Vlidtion of A Personl Electronic Dosimeter nd Its Use In Assessing How Individul Tsks Contribute to Overll Stff Dose During 18 FDG PET Scnning; How Low Cn It Go? C Renshw, G Pwson, I Mbutu-Austin, S Brtley, A Brdley, Centrl Mnchester University Hospitls, Mnchester, UK Anlysis of Methods for Technologist Dose Reduction in PET-CT Deprtment L Alves, J Joemon, A Jcob, C Abreu, S Pereir, R Cbrl, E Woods, PET Imging Centre, Division of Imging Sciences & Biomedicl Engineering, King's College London, King s Helth Prtners, St. Thoms Hospitl, London, UK Opertionl Chnges to Accommodte SPECT-CT Bone Studies J Thompson-Peters, D Dwkins, J O'Brien, N Smith, W Thomson, A Jefferies, City Hospitl, Birminghm, UK Imging Time nd Collimtor Choice when OSEM with Resolution Modelling Is Used For Myocrdil Perfusion SPECT Reconstruction - A Phntom Study A List, Imperil College Helthcre NHS Trust, London, UK PRESIDENT'S RECEPTION - EXHIBITION HALL MEETING ROOM CLINICAL PRACTITIONERS GROUP AGM MEDICS FORUM - DISCUSS 'HOT TOPICS' Chir Dr Sbin Dizdrevic 1. New Services: Impct on ptients mngement Prof Gry Cook King's College London 2. Workforce - Updte 3. New curriculum/trining: Informtion for clinicl nd eductionl supervisors 4. PET-CT ntionl contrct 5. Rdiophrmceuticls: production nd supply Pge 24 BNMS 43rd Annul Meeting

25 FULL PROGRAMME TUESDAY 28TH APRIL AUDITORIUM MASTERCLASS IV: LUNG CANCER Dr Brent Drke & Dr Richrd Grhm Aetiology, pthogenesis nd dignosis of Lung cncer Dr Vineet Prksh St Peter's Hospitl Surrey Current Sttus of Mngement of lung cncer: Focus on Surgicl Perspective Mr Dvid Lwrence University College London Hospitls NHS Foundtion Trust PET in lung cncer: New Chnges in Prctice nd Chllenges Dr Prksh Mnohrn The Christie NHS Foundtion Trust Questions nd Answers Dr Brent Drke, Plymouth Hospitls NHS Trust Te & Coffee in the Exhibition Hll MASTERCLASS V: LYMPHOMA Chir Dr Frncis Sundrm & Dr Lorenzo Bissoni Aetiology, pthogenesis nd dignosis of Lymphom: Dr Irfn Kyni Institute of Nucler Medicine, UCLH Current Sttus of Mngement of Lymphom Dr Jonthn Lmbert University College London Hospitls NHS Foundtion Trust PET/CT in Lymphom: Focus on Recent Chnge in Guidelines Dr Slly Brrington PET Centre t St Thoms', King's College London Questions nd Answers Dr Frncis Sundrm University Hospitl Southmpton Lunch & Meet Industry in the Exhibition Hll Moderted Poster Session ANNUAL LECTURE Chirs Dr Alp Notghi & Dr Gopinth Gnnsegrn "THE EVOLVING ROLE OF CLINICAL MOLECULAR IMAGING IN MULTI-DISCIPLINARY CANCER CARE": Professor Homer Mcpinlc, MD Anderson Cncer Centre, The University of Texs WHAT IF YOU COULD SEE PEOPLE S THOUGHTS, FEELINGS?: EMPATHY: EXPLORING HUMAN CONNECTION (VIDEO 1) COURTESY: CLEVELAND CLINIC, USA WHAT IF YOU COULD SEE PEOPLE S THOUGHTS, FEELINGS?: EMPATHY: EXPLORING HUMAN CONNECTION (VIDEO 2) COURTESY: CLEVELAND CLINIC, USA GA-68-PSMA PET/CT IMAGING: THE GAME CHANGER, Dr Kumr Kllur Helthcre Globl Enterprises Ltd, Bnglore, Krntk, Indi Te & Coffee in the Exhibition Hll BNMS ANNUAL GENERAL MEETING SYNDICATE RADIOPHARMACY: MOLYBDENUM SUPPLY Chirs J Crosdle & Dr B Ellis Overview of Mo-99 Globl Supply Dr B Neilly, Glsgow Royl Infirmry Options for Tc-99m production in the UK Prof A Perkins. Nottinghm University Hospitls NHS Trust, Nottinghm The Cndin Tc-99m products: Synthesis nd specifictions Dr B Eliis Centrl Mnchester University Hospitls NHS Foundtion Trust Regultory Issues ffecting the cyclotron production of Tc-99m Dr J Bllinger Guy's nd St Thoms' NHS Foundtion Trust How will you mnge Molybdenum shortge from ? GE Response Julie Woodlnd, GE Helthcre Ltd Allince/ IBA Response: Howrd Mrsh, Chief Finncil Officer, Allince Medicl UK nd Northern Europe Mllinckrodt Response: Roy Brown Senior Director of Strtegic Allinces Pnel discussion Te & Coffee in the Exhibition Hll RADIOPHARMACY: PROFERRED PAPERS Chirs J Crosdle, Dr B Ellis BNMS 43rd Annul Meeting Pge 25

26 FULL PROGRAMME TUESDAY Vlidtion of Extended Expiry of 99m Tc Lbelled Rdiophrmceuticls VJ Gibson 1, A Al-Mosswi1, JR Bllinger 1,2, 1 Guy's nd St Thoms' Hospitl, London, UK, 2 King's College London, London, UK Optimiztion of Cyclotron Production of Zirconium 89 A M Dbkowski, C Mrshll, Crdiff University, Crdiff, UK Rpid 68 G-Rdiolbelling of Proteins In Mild Conditions Exploiting A Novel Tris(Hydroxypyridinone) Bifunctionl Cheltor C Imberti, M.T M, P.J Blower, King's College London, London, UK One-Step, Mild Efficient 68 G Cold PET Kits: Performnce Chrcteristics nd Robustness of Tris(Hydroxypyridinone) Cheltors. J Young 1, M Cooper 1, B Pterson 1, M M 1, J Bllinger 1, S Nwz 1, D Berry 1, R Hider 2, G Mullen 1, P Blower 1, 1 King's College London, Division of Imging Sciences nd Biomedicl Engineering, London, UK, 2 King's College London, Institute of Phrmceuticl Science, London, UK 1st Plce Student Prize A Ntionwide Audit On Solid Gstric Emptying: Assessing Disprity Amongst The Deprtments S Hnsrod, A Notghi, J Crosdle, Sndwell nd west Birminghm Hospitl NHS Trust, Birminghm, UK Impct of Chnges to Cell Lbelling Technique On The Results of Indium-Lbelled Pltelet Imging For ITP Ptients FI McKiddie 1, J Phillips 1, D Grhm 2, H Wtson 3, RT Stff 1, 1 Nucler Medicine Deprtment, NHS Grmpin, Aberdeen, UK, 2 Phrmcy Deprtment, NHS Grmpin, Aberdeen, UK, 3 Hemtology Deprtment, NHS Grmpin, Aberdeen, UK Rdiophrmceuticl Sciences Group AGM Lunch & Meet Industry in the Exhibition Hll Moderted Poster session ANNUAL LECTURE "THE EVOLVING ROLE OF CLINICAL MOLECULAR IMAGING IN MULTI-DISCIPLINARY CANCER CARE": Professor Homer Mcpinlc, MD Anderson Cncer Centre, The University of Texs.-16. TRAINEES FORUM Deen Nerimn Te & Coffee in Exhibition Hll SYNDICATE INVITED REVIEW & PROFFERED PAPERS Chirs Dr Robert Reid & Dr Pul Ryn The cost of Nuc Med: HRG codes nd Triffs. Nthn Abbotts Helth nd Socil Cre Informtion Centre The cost of Nuc Med: HRG codes nd Triffs. Srh Allen Guy's nd St Thoms' NHS Foundtion Trust The cost of Nuc Med: HRG codes nd Triffs. Dr Mrgret Hll Royl Free London NHS Foundtion Trust Trils nd Tribultions of mobile PET/CT service. Dr Clire Bedsmoore Norfolk nd Norwich University NHS Foundtion Trust Te & Coffee in the Exhibition Hll NEUROLOGY: INVITED REVIEW & PROFERRED PAPERS Chirs Dr Vikrm Lele & Dr Simon Hughes Who should be considered for n myloid scn? Experiences from dementi MDT Dr Richrd Perry, Consultnt Neurologist, Imperil College Helthcre NHS Trust, London Eli Lilly nd Compny LTD hve sponsored the content of this session The Effect of Vrious Types nd Severity of Motion on Dtscn Imges nd Quntifiction using Novel Method G Jmes, A Notghi, City Hospitl, Birminghm, UK Assessing the Dignostic Impct of FDG-PET-CT Imging on Finl Dignosis in Ptients with Mild Cognitive Impirment K Dy 1, A Hosur 1, G Rczek 3, B H Ridh 1, A H Mhdi 2, S Dizdrevic 1, 1 Brighton nd Sussex University Hospitls Trust, Brighton, Est Sussex, UK, 2 University of Shrjh, Khor Fkkn, United Arb Emirtes, 3 Sussex Prtnership NHS Foundtion Trust, Worthing, Est Sussex, UK Pge 26 BNMS 43rd Annul Meeting

27 FULL PROGRAMME TUESDAY Initil Experience of The Utility of An Automted Quntittive Cortex Mpping Softwre For FDG PET-CT Assessment of Cerebrl Metbolism. J Cin, J Hill, Lncshire Teching Hospitls NHS Trust, Preston, Lncshire, UK Joint 2nd Plce Student Prize Amyvid Scn Time: How Low Cn You Go? AJ Cole 1, L Perry 1, B Willims 2, W Svensson 2, KS Nijrn 1, Z Win 2, 1 Rdiologicl Sciences Unit, Imperil College Helthcre NHS Trust, London, UK, 2 Nucler Medicine Deprtment, Imperil College Helthcre NHS Trust, London, UK Prognostic Vlue of 18 F-Florbetpir Scn: A 36-Month Follow Up Anlysis Using ADNI Dt M Lu 1, M Pontecorvo 1, A Siderowf 1, AD Joshi 1, M Devous 1, M Mintun 1, A Lenox-Smith 2 1 Avid Rdiophrmceuticls, Inc, Phildelphi, PA, USA, 2 Lilly UK, Lilly House, Bsingstoke, Hmpshire, UK Potentil Effect of Amyloid Imging on Dignosis nd Intended Mngement of Ptients with Cognitive Decline: Impct of Approprite Use Criterion. G Dell'Agnello 1, M Pontecorvo 1, M Lu 1, C Hunter 1, AK Aror 1, M Mintun 1, A Lenox-Smith 2, 1 Eli Lilly nd Compny or wholly owned subsidiry, Indinpolis, IN, USA, 2 Lilly UK, Lilly House, Bsingstoke, Hmpshire, UK A Comprison of the Psychologicl Burden Cused by PET-MRI nd PET-CT scns R Shortmn 1,2, D Nerimn 1,2, J Hoth 1,2, L Millner 1,2, R Endozo 2, G Azzoprdi 1,2, C O'Mer 2, J Bomnji 2,1, A Groves 1,2, 1 University College London, London, UK, 2 University College Hospitl, London, UK Lunch & Meet Industry in the Exhibition Hll Moderted Poster Session ANNUAL LECTURE "THE EVOLVING ROLE OF CLINICAL MOLECULAR IMAGING IN MULTI-DISCIPLINARY CANCER CARE": Professor Homer Mcpinlc, MD Anderson Cncer Centre, The University of Texs Te & Coffee in Exhibition Hll NUCLEAR MEDICINE: MISCELLANEOUS PROFFERED PAPERS Chir Dr Jckie Jmes Prthyroid Imging: Overview Dr Vineet Prksh, Ashford nd St. Peter s Hospitls NHS Foundtion Trust Plnr nd SPECT Ventiltion/Perfusion Imging nd Computed tomogrphy Pulmonry Angiogrphy For The Dignosis of Pulmonry Embolism: A Systemtic Review, Met-Anlysis of The Literture, Cost Effectiveness Anlysis, nd Dose Comprison. JJ Phillips, RA Stff, J Striton, Grmpin NHS, Aberdeen, UK Lobr Quntifiction of Lung Perfusion nd Ventiltion: A Comprison of Two Different Processing Methods Using SPECT VQ/CT CD Bker, S Gregg, J Biley, JC Fowler, SR Underwood, K Wechlekr, Royl Brompton & Hrefield NHS Foundtion Trust, London, UK Gstric Emptying Scintigrphy In Peditric Gstropresis; Are we Using The Correct Norml Rnges? S Mohmmdi, B kerl, H Bnoub, S Chong, A Prthipun, St Helier Hospitl, London, UK Our Experience with the SNM Gstric Emptying Protocol N Vennrt 1,2, G Roberts 2, J Atkinson 1, D Limmer 1, I Wells 1, Y Yinnikou 3, E Jefferson 2 1 Regionl Medicl Physics Dept. North Tees nd Hrtlepool Foundtion Trust Unit, Hrtlepool, UK, 2 Regionl Medicl Physics Dept. County Durhm nd Drlington Foundtion Trust Unit, Durhm, UK, 3 County Durhm nd Drlington Foundtion Trust, Durhm, UK SYNDICATE CLINICAL PRACTITIONERS: CONTINUING EDUCATION SERIES 3 Chirs S Johns & P Delf Nucler Medicine nd Therpy. Dr Shunk Nvlkissor Royl Free London NHS Foundtion Trust Nucler Medicine nd Therpy: Role of technologists Ivy Vito, Royl Free London NHS Foundtion Trust Rdition Sfety in Rdionuclide therpy Dr Jeff Jones, The Royl Free London NHS Foundtion Trust PET/CT: Delivering high qulity service: A technologists perspective Dr Joemon John, Clinicl PET centre, Guys & St Thoms NHS Hospitl Te & Coffee in the Exhibition Hll CLINICAL PRACTITIONERS CONTINUING EDUCATION SERIES 4 Chirs L Rowling & C Lory Nucler Medicine nd Peditric brin imging Dr Lorenzo Bissoni Gret Ormond Street Hospitl for Children NHS Foundtion Trust Gted blood pool imging: Technicl chllenges nd solutions Dr Prthibn Arumugm Centrl Mnchester University Hospitls BNMS 43rd Annul Meeting Pge 27

28 FULL PROGRAMME TUESDAY CT Workshop for Nucler Medicine Technologists Prt 2 (bdomen & pelvis) Dr Vineet Prksh Ashford nd St. Peter s Hospitls NHS Foundtion Trust Red with the Experts (Clinicl): Interctive Clinicl Quiz Dr Prthibn Arumugm Centrl Mnchester University Hospitls - NHS Foundtion Trust nd Dr Brent Drke Plymouth Hospitls NHS Trust Lunch & Meet Industry in the Exhibition Hll Moderted Poster Session ANNUAL LECTURE "THE EVOLVING ROLE OF CLINICAL MOLECULAR IMAGING IN MULTI-DISCIPLINARY CANCER CARE": Professor Homer Mcpinlc, MD Anderson Cncer Centre, The University of Texs Te & Coffee in Exhibition Hll PET/CT CASE REVIEW: "DEALING WITH THE CLINICAL CHAMELEON" Modertors Dr Teres Szyszko & Dr Irfn Kyni Interesting PET/CT Cses (Brin, hed & Neck, lung, Miscellneous) Dr Teres Szyszko PET Imging Centre t St Thoms', Dr Simon Wn Interesting PET/CT Cses (Lymphom, CRC, NET, Miscellneous) Dr Irfn Kyni Institute of Nucler Medicine, UCLH Pge 28 BNMS 43rd Annul Meeting

29 FULL PROGRAMME WEDNESDAY 29TH APRIL AUDITORIUM YOUNG INVESTIGATORS PRIZE Chirs Dr Frncis Sundrm & Prof S Vinjmuri Negtive 18 FDG-PET-CT My Exclude Residul Or Recurrent Disese In Anl Cncer A Tegle 1, D Gilbert 1, J Jones 2, G Burkill 1, F McKinn 1, S Dizdrevic 1, 1 Brighton nd Sussex University Hospitls NHS Trust, Brighton, UK, 2 King's college Hospitl NHS Foundtion Trust, London, UK G DOTATATE PET-CT: Wht Is The Minimum Activity Necessry to Mintin Lesion Detectbility In The Liver? H McMeekin, S Nvlkissoor, D McCool, Royl Free London NHS FT, London, UK Improving SUV Normlistion for 18 F-FDG PET-CT using CT Ft Segmenttion. G Woolley, M Burniston, H McMeekin, F Wickhm, T Wgner, D McCool, Royl Free Hospitl, London, UK Ventiltion/Perfusion (V/Q) Scintigrphy with SPECT nd SPECT-CT: Moving From Probbility to Holistic Reporting. C Sit 1, R Mndegrn 2, C Sibley-Allen 3, D Dsgupt 3, G Gnnsegrn 3, 1 King's College London, London, UK, 2 Deprtment of Rdiology, Guy's nd St Thoms' NHS Foundtion Trust, London, UK, 3 Deprtment of Nucler Medicine, Guy's nd St Thoms' NHS Foundtion Trust, London, UK REPORT ON TRAVELLING FELLOWSHIP REPORT 20 Dr Michel Ky, University Hospitl Southmpton. Trvelling Fellowship Awrd Winner Te & Coffee in the Exhibition Hll NUCLEAR MEDICINE: MISCELLANEOUS Chirs Dr Richrd Grhm & Srh Allen Setting up Alphrdin Therpy Service Dr Frncis Sundrm University Hospitl Southmpton Infection Imging in Orthopedics, Prof Sobhn Vinjmuri Royl Liverpool University Hospitl Movers nd Shkers in Endocrinology Dr Rkesh Sjjn University College London Hospitls NHS Foundtion Trust AWARDS CEREMONY HIGHLIGHTS LECTURE DR BRIAN NEILLY Chirs Dr Alp Notghi Lunch nd Close of Meeting SYNDICATE RADIONUCLIDE RADIOTHERAPY PROFERRED PAPERS Chir Dr Shunk Nvlkissor Estblishing A Nucler Medicine Led Rdium-223 (R-223) Rdionuclide Therpy Service: South of Englnd Single Centre Experience M Ky, R Kulnthivelu, S Johns, J Hrris, S Greenslde, C Zvvmwe, S Rhodes, M Guy, F Sundrm, University Hospitl, Southmpton, UK Rdium- 223 Rdionuclide Therpy For Ptients With Symptomtic Bony Metsttic Cstrtion Resistnt Prostte Cncer (mcrpc): Initil Clinicl Experience from University Hospitl Southmpton (UHS) R Kulnthivelu, M Ky, S Johns, F Sundrm, University Hospitl, Southmpton, UK Cn Low Dose Rdioiodine Thyroid Abltion Be Performed As A Dy Cse? A Retrospective Study Into Activity Retention Times S Sccrm 1, M Newell 1, I Murry 2, D towey 3, 1 Brts Helth NHS Trust, London, UK, 2 Royl Mrsden NHS Foundtion Trust, Sutton, UK, 3 Imperil College Helthcre NHS Trust, London, UK A Softwre Phntom for Testing Dosimetric Clcultions For Multi-Centre Studies - Appliction to 177 Lu-DOTATATE nd The UK Internl Dosimetry Users Group L Liviertos 1, M Aldridge 2, M Guy 3, E Kloginni 4, DR McGown 5, B Rojs 6, J Tipping 7 1 Guy's nd St Thoms' NHS Foundtion Trust, London, UK, 2 University College London Hospitls NHS Foundtion Trust, London, UK, 3 University Hospitl Southmpton NHS Foundtion Trust, Southmpton, UK, 4 King's College Hospitl NHS Foundtion Trust, London, UK, 5 Oxford University Hospitls NHS Trust, Oxford, UK, 6 Royl Brompton & Hrefield NHS Foundtion Trust, London, UK, 7 Christie NHS Foundtion Trust, Mnchester, UK BNMS 43rd Annul Meeting Pge 29

30 FULL PROGRAMME WEDNESDAY Rdition Protection Considertions For 177 Lutetium- Dottte PRRT: From Delivery to Dischrge. R Fernndez, S-M Gould, L Liviertos, C Sibley-Allen, K Admson, P Gerghty, S Allen, T Brothwood, F Hssn, V Lewington, Guy's & St Thoms' Hospitl NHS Foundtion Trust, London, UK Brest Dose From Lcttion Following 131 I Tretment WH Thomson 1, C Lewis 2, 1 City Hospitl, Physics nd Nucler Medicine, Birminghm, UK, 2 City Hospitl, Mternity, Birminghm, UK Dosimetry nd Survivl in Ptients with Bone Metstses from Prostte Cncer Treted with 186 Re-HEDP A M Denis-Bcelr 1, A Divoli 2, S Chittenden 2, D P Dernley 1, J M O'Sullivn 3, Y Du 2, K J Frisch 1, G D Flux 2, 1 Institute of Cncer Reserch, London, UK, 2 Royl Mrsden Hospitl, London, UK, 3 Queen's University Belfst / Northern Irelnd Cncer Centre, Belfst, UK QUALITY OF LIFE: Ptient Response fter 1st Tretment (PRRT) I Mteo-Vito, R Leshen, H McMeekin, S Nvlkissoor, Royl Free London NHS Foundtion Trust, London, UK A Survey of Ptient Restrictions For 131 I Thyrotoxicosis Tretment; Clculted Doses nd Their Implictions. WH Thomson, City Hospitl, Birminghm, UK R-Dichloride Tretment In Clinicl Prctice: Extent of Bone Disese nd Alkline Phosphtse (ALP) Response Vs. Outcomes S Dizdrevic, M Jessop, M Aplin, N Singh, A Hosur, K Dy, A Nikpot, F McKinn, A Robinson, Royl Sussex County Hospitl, Brighton, UK Te & Coffee in the Exhibition Hll AWARDS CEREMONY HIGHLIGHTS LECTURE DR BRIAN NEILLY Chirs Dr Alp Notghi Lunch nd Close of Meeting SYNDICATE NUCLEAR MEDICINE: MISCELLANEOUS PROFERRED PAPERS 2 Chir Prof Drzen Huic & Prof Jsn Mihilovic PET Imging of Chnges in Copper Metbolism Associted With Alzheimer's Disese: Potentil New Dignostics J Bguñ torres, E ndreozzi, A Gee, P Blower, King's College London, London, UK Pge BNMS 43rd Annul Meeting ROC Comprison of Scintigrphic Prthyroid Loclistion Techniques. KC Cockburn 1, N Ahmed 2, GR Avery 2, GA Wright 1, 1 Deprtment of Nucler Medicine, Cstle Hill Hospitl, Cottinghm, Est Riding of Yorkshire, UK, 2 Deprtment of Rdiology, Cstle Hill Hospitl, Cottinghm, Est Riding of Yorkshire, UK Iodine-125 Seeds in the Loclistion of Brest Tumours: A UK First! R Pece, N Khonji, The Newcstle upon Tyne NHS Foundtion Trust, Newcstle upon Tyne, UK Quntifiction of The Activity of Tritium Produced During The Routine Synthesis of 18 F Fluorodeoxyglucose For Positron Emission tomogrphy MA Tlboys 1,2, C Mrshll 1, S Bukhri 1, WD Evns 2,3, 1 Wles Reserch nd Dignostic Positron Emission tomogrphy Imging Centre (PETIC), School of Medicine, Crdiff University, Heth Prk, Crdiff CF14 4XN, Wles, UK, Crdiff, UK, 2 Medicl Physics nd Clinicl Engineering, Crdiff nd Vle University Helth Bord, University Hospitl of Wles, Heth Prk, Crdiff CF14 4XW, Wles, UK, Crdiff, UK, 3 Institute of Medicl Engineering nd Medicl Physics, School of Engineering, Crdiff University, Queen s Buildings, The Prde, Crdiff CF24 3AA, Wles, UK, Crdiff, UK Locl Dignostic Performnce Using Seril Brin Imging With 99m Tc-HMPAO nd 123 I-FP-CIT (DTSCAN) In The Evlution of Ptients With Dementi When Differentiting Alzheimer's Disese From Lewy Body Dementi. R Brown, PS Chuh, R Berhne Menghis, S Vinjmuri, Royl Liverpool University Hospitl, Liverpool, UK Quntittive Anlysis of FDG PET nd MPS Imges For Dignosis nd Follow Up In Crdic Srcoidosis B Rojs, L Hossen, S Gregg, V Kournos, K wechlekr, Royl Brompton Hospitl, London, UK Sensitivity of QC Methods For Slope-Intercept GFR Clcultion H McMeekin 1, F Wickhm 1, M Brnfield 2, M Burniston 1, 1 Royl Free London NHS FT, London, UK, 2St Jmes's University Hospitl, Leeds, UK Identifiction of The Most Accurte Single-Smple Technique For Mesurement of Glomerulr Filtrtion Rte (GFR) For All Ages H McMeekin, M Burniston, F Wickhm, M Brnfield, Royl Free London NHS Foundtion Trust, London, UK Te & Coffee in the Exhibition Hll AWARDS CEREMONY HIGHLIGHTS LECTURE DR BRIAN NEILLY Chirs Dr Alp Notghi Lunch nd Close of Meeting

31 POSTERS P1 P2 P3 P4 P5 P6 Follow-up studies of 18 F sodium fluoride PET/CT bone studies in ptients with brest cncer. Plnr bone scintigrphy versus 18 F sodium fluoride PET/CT: which re we doing nd why? R.K. Kulshresth,b, S. Vinjmuri b,c, P. Hogg c nd A. Englnd c Centrl Mnchester University Teching Hospitls NHS Foundtion Trust, Mnchester, b Royl Liverpool University Teching Hospitls NHS Foundtion Trust, Liverpool nd c University of Slford, Slford, UK How useful re our SPECT/CT bone scns? J. O Brien, D. Dwkins, W.H. Thomson, J. Courtney, G.D. Jmes nd S. Toms Hernndez Sndwell & West Birminghm Hospitls NHS Trust, West Midlnds, UK Initil ssessment of xspect qunt for SPECT/CT bone scnning V. Rowse, L. Vss nd A.G. Irwin St. George s Hospitl, London, UK Dose djustment for bone studies on obese ptients: where s the evidence? F.H. Brrck,b, G. Bologn b, M. Brnco b, O. Ghfoor b, P.J. Hinton, V. Prksh b, J.Q. Scuffhm nd J.J. Simpson b Royl Surrey County Hospitl, Guildford, Surrey nd b Sint Peter s Hospitl, Chertsey, Surrey, UK SPECT-CT imging in osteoporosis relted bck pin Pul Ryn Medwy Mritime Hospitl, Gillinghm, UK P6 Detection of distolic ventriculr interction in chronic hert filure from MUGA scns P7 P8 P9 P10 P11 F.I. McKiddie, S. Singh b nd R.T. Stff Nucler Medicine Deprtment, NHS Grmpin nd b Crdiology Deprtment, NHS Grmpin, Aberdeen, UK The impct of computed tomogrphy crdic ngiogrphy (CTCA) on the myocrdil perfusion scintigrphy (MPS) service: retrospective service evlution study H.G. Whiteley-Jones, J. Dene, S. Dizdrevic nd V. Rmn Brighton nd Sussex University Hospitls NHS Trust, Brighton, UK Assessment of the vribility of left ventriculr ejection frction (LVEF) between softwre lgorithms in rdionuclide ventriculogrphy (RNVG) J. Robinson, J. Prosser b, G.S.M. Cheung c, A. Trbuck b, S. Alln, G. McMster, S. Reid nd W. Mrtin Glsgow Royl Infirmry, Glsgow, b Rigmore Hospitl, Inverness, UK nd c Aberdeen Royl Infirmry, Aberdeen, UK Phse nlysis of rdionuclide ventriculogrphy: ssessment of herceptin crdiotoxicity A. Al-Jbri b, C. Pterson,b, J. Robinson, W. Mrtin, S. Reid nd S. Smith Nucler Crdiology, Glsgow Royl Infirmry, Glsgow nd b School of Medicine, Glsgow University, Glsgow, UK Vlue of CT in MPI: ttenution correction nd coronry clcium ssessment N. Bebbington, Y. Whid, B. Hollowy nd R. Steeds Queen Elizbeth Hospitl Birminghm, Birminghm, UK A negtive stress only myocrdil perfusion provides excellent prognostic ccurcy D.S. Bulughpitiy, A. Feben, M.P. Avison, J. Foley nd J. Mrtin P12 P13 P14 P Brdford Teching Hospitls NHS Trust, Brdford, UK Ppillry thyroid cncer with pleurl metstses J. Siddiqui, S. Sccrm b, E. Nowosinsk b, W. Drke c nd H. Jn b Deprtment of Rdiology, St Brtholomew s Hospitl, b Deprtment of Nucler Medicine, London, UK nd c Deprtment of Endocrinology, London, UK The role of functionl nd rdiology imging in evlution of metsttic prthyroid cncer C. Leung, M. Newell b, E. Nowosinsk b, W. Drke c nd H Jn b Rdiology Deprtment, St. Brtholomew s Hospitl, b Nucler Medicine Deprtment St. Brtholomew s Hospitl nd c Endocrinology Deprtment, St Brtholomew s Hospitl, London, UK Comprison of two doses of rdio-iodine for the tretment of thyrotoxicosis nd correltion with thyroid uptke imging pre-tretment S. Svrids, G. Roberts b, E. Jefferson b nd K. Whicker c North Tyneside Generl Hospitl, Tyne-nd- Wer, UK, b University Hospitl North Durhm, Durhm, UK nd c Hrtlepool Memoril Hospitl, Hrtlepool, UK Audit of rdioiodine therpy in benign thyroid disese t est kent university hospitls ccording to the royl college of physicins guidelines E. Nikolou nd G. Shbo Est Kent Hospitls University NHS Foundtion Trust, Kent nd Cnterbury Hospitl, Ethelbert Rod, Cnterbury, Kent, UK BNMS 43rd Annul Meeting 31

32 POSTERS P16 Exploring possible cuses of venous uptke of 99m Tc MIBI A. Smout, J. Hll, A. Fullbrook, J. Wrd nd L. Wright Frimley Prk Hospitl, Frimley, Surrey, UK P17 Mucinous denocrcinom of unknown origin: n unusul thyroid presenttion A. Hosur, A. Tegle, M. Koenig, A. Riney, J. Simpson nd S. Dizdrevic Brighton nd Sussex University Hospitls NHS Trust, Brighton, UK P18 Squmous cell crcinom of the thyroid: cse series nd literture review A. Tegle, A. Hosur, C. Zmmit, V. Rmn, N. Singh nd S. Dizdrevic Brighton nd Sussex University Hospitls NHS Trust, Brighton, UK P19 Review of prthyroid imging t est kent university hospitls in 2006 nd 2011 to evlute the reproducibility of prthyroid imging in correltion with surgery nd histopthology results P. Ri, K. Bryce nd G. Shbo Kent nd Cnterbury Hospitl, Est Kent Hospitl Foundtion Trust, Cnterbury, Kent, UK P20 SPECT Ventiltion/Perfusion (V/Q) quotient: complimentry tool to evlute mtched nd mismtched defects? FR Green b, FU Hssn, C Sibley-Allen nd G Gnngesrn Guy s nd St Thoms Hospitls NHS Trust, London, UK nd b King s College London, London, UK P21 Ventiltion-Perfusion single photon emission computed tomogrphy (VQ SPECT) nd computed tomogrphy pulmonry ngiogrphy (CTPA) correltion in the detection of pulmonry embolism (PE) C. Low, J. Cullis, A. Jennings, N. Willims nd O. Adesny University Hospitls Coventry nd Wrwickshire NHS Trust, Coventry, West Midlnds, UK P22 Initil experience of DMSA SPECT-CT in the ssessment of peditric renl clculi F. Ashford, E. Joel b, L. Bissoni, M. Esty nd G. Heth Gret Ormond Street Hospitl for Sick Children NHS Foundtion Trust, London, UK nd b Brts Helth NHS Trust, London, UK P23 Bone scn with low-dose SPECT-CT in peditric bck pin: cquisition detils, dosimetry, nd imge qulity E. Ali, F. Hussin, E. Joel,b, G. Heth, L. Bissoni,b, M. Esty nd R. Ndrjh Gret Ormond St Foundtion Trust, nd b Brts Helth NHS Trust, London, UK P24 ISAS ccredittion: wht does it men to nucler medicine deprtment? D. Gillett nd H. Rose Addenbrookes Hospitl, Cmbridge, UK P25 Technetium-99m-MIBI SPECT/CT In Hyperprthyroidism - Institutionl Review M. Khlid Nwz, S. Mufy, H. Bshir nd A. Hssn Deprtment of Nucler Medicine Shukt Khnum Memoril Cncer Hospitl & Reserch Centre, Lhore, Pkistn P26 Review of first 6 months usge of 18 F florbetpir brin imging P.S. Chuh, R. Brown nd S. Vinjmuri Nucler Medicine Deprtment, Royl Liverpool University Hospitl, Liverpool, UK P27 Impct of child-friendly environment on reducing the need for sedtion in imging A. Rshid, H. Ahmed, M. Khlid Nwz, H. Bshir nd H. Ali Shukt Khnum Memoril Cncer Hospitl & Reserch Centre, Lhore, Pkistn P28 The initil experience of the dded vlue of SPECTCT in generl hospitl setting: pictoril review E. Owens, D. Sllomi, J. Ewer nd H. Anderson Estbourne District Generl Hospitl, Estbourne, UK P29 Reproducible Lymph-To-Blood trnsfer of 99m Tcnnocolloid in ptient with bnorml lymphtic function G. Kermid, M. Lee, N. Singh nd A.M. Peters Deprtment of Nucler Medicine, Brighton nd Sussex University Hospitls NHS Trust,, Brighton, UK P A review of GFR clernce studies in n oncology popultion: evluting the potentil for chemotherpy over-prescription A. Bker nd M. Richrdson Jmes Cook University Hospitl, Middlesbrough, UK P31 Locl experience of using intrvenous 99m Tc mcroggregted lbumin in the dignosis of heptopulmonry syndrome R. Brown, P.S. Chuh, I. Hufton nd S. Vinjmuri Royl Liverpool University Hospitl, Liverpool, UK Pge 32 BNMS 43rd Annul Meeting

33 POSTERS P32 MIBI renl nd heptic SPECT rte constnts nd correltion with ABCB1 genotypes in ptients receiving ciclosporin tretment S. Dizdrevic,b, M.J. Newport b, M. Lee, M. Aplin, J. Bllinger c, E. Derrick, L. Atkinson nd A.M. Peters,b Brighton & Sussex University Hospitls NHS Trust, b Brighton & Sussex Medicl School, Brighton, UK nd c Guy s nd St Thoms Trust, London, UK P33 Reducing non completed PET/CT scns - potentil qulity improvement inititive A. Nunes, G. Beynon nd W.L. Wong Pul Stricklnd Scnner Centre - Mount Vernon Hospitl, Northwood, Middlesex, UK P34 The HIDA scn: mking mel of it M. Doln, G. Ainslie-McLren, A. Bolster, J. Neilly nd S. Hn Glsgow Royl Infirmry, Glsgow, UK P35 Estblishing locl CT DRLs for SPECT/CT imging A. Prmiths nd A.G. Irwin St. George s Hospitl, London, UK P36 A novel technique to investigte the effect of ptient motion for DTSCAN studies G. Jmes nd A. Notghi City Hospitl, Birminghm, UK P37 Utility of PET-CT in criticl cre ptients - cse of encephlitis dignosed on PET-CT performed in ventilted ptient J. Cin nd J. Hill Lncshire Teching Hospitls NHS Trust, Preston, Lncshire, UK P38 The complementry role of 18 F-FDG PET nd MR in evluting the Cortico-Ponto- Cerebellr regions: cse study J. Siddiqui, C. Leung, Y. Bouchreb, J. Evnson, H. Jn nd A. Hroon Brts Helth NHS Trust, London, UK P39 Unusul findings of CADISIL like ppernces in ptient with denocrcinom of lung: prneoplstic versus vsculr disese A. Hosur, N. Singh, K. Dy, C.D. Good, B. Ridh nd S. Dizdrevic Brighton nd Sussex University Hospitls NHS Trust, Brighton, UK P40 Influence of slice overlp on positron emission tomogrphy imge qulity C. McKeown, G. Gillen, M.F. Dempsey nd C. Findly Grtnvel Generl Hospitl, NHS Greter Glsgow nd Clyde, Glsgow, UK P41 Continuous bed motion PET: should we go with the flow? G.A. Wright, E. Ppdopoulos, J. Reid b nd G. Avery Hull nd Est Yorkshire Hospitls NHS Trust, Cottinghm, UK nd b Allince Medicl Ltd, Wrwick, UK P42 Evolving role of 18 F-FDG PET/CT in the investigtion of pyrexi of unknown origin N.S.A. Rfr, P. Vs, N. Mulhollnd, G. Vivin, A. Eccles nd N. Gulliver King s College Hospitl NHS Trust, London, UK P43 Unusul neuroendocrine tumour metstses detected on 68 G-DOTA-Peptide PET scns D. Penchrz, H. McMeekin nd S. Nvlkissoor Royl Free London NHS Foundtion Trust, London, UK P44 Non-physiologicl, non-neuroendocrine tumour uptke in 68 G-DOTA-peptide PET scns D. Penchrz, H. McMeekin nd S. Nvlkissoor Royl Free London NHS Foundtion Trust, London, UK P Retrospective study investigting the role of FDG-PET/CT for ptients presenting with weight loss C. Tng, H. McMeekin nd T. Wgner Royl Free Hospitl, London, UK P46 Implementtion of 18 F-FDOPA nucleophilic synthesis using the trsis llinone synthesiser t PETIC S.H. Bukhri, K.C. Probst, A. Dbkowski, D. Hrdwick nd C. Mrshll Crdiff University-PETIC, Crdiff, UK P47 Disppering pncres - cse of pncretic cncer detected on 18 F-choline PET-CT G. Burkill, G. Kermid, A. Nikpot, D. Hwkes nd S. Dizdrevic Deprtment of Imging, Brighton Sussex University Hospitls NHS Trust, Brighton, UK P48 FDG PET/CT in crcinom of unknown primry S. Shhipsnd nd S. Nvlkissoor Deprtment of Nucler Medicine, Royl Free London NHS Foundtion Trust, London, UK P49 The use of FDG PET-CT in suspected prneoplstic neurologicl syndromes: the experience of singlecentre institution G. Buckley, H. McMeekin nd T. Wgner Royl Free London NHS Trust, Royl Free Hospitl, Pond Street, London, UK BNMS 43rd Annul Meeting Pge 33

34 POSTERS P50 18 F-fluoromethylcholine ( 18 F-FMC) prostte imging: cse study T. Letchford, A. Nunes, A. Gogbshin nd W. Wong Pul Stricklnd Scnner Centre, Middlesex, UK P51 The dded vlue of 68 G PET compred to CT for dignosis nd mngement of neuroendocrine tumours N. Klsy, R. Fernndo nd S. Vinjmuri Royl Liverpool Hospitl, Liverpool, UK P52 The prevlence nd relevnce of incidentl pthology on routine FDG PET-CT A. Kmil nd R. Gntr Queen s Medicl Centre Nottinghm, Nottinghm, UK P53 Results of UK survey of PET technology nd imging protocols for 18 FDG-PET in oncology L.C. Pike, H.A. Willims b, I.S. Armstrong b nd M. Burniston c PET Imging Centre, St Thoms Hospitl, Division of Imging Sciences nd Biomedicl Engineering, King s College London, King s Helth Prtners, London, UK, b Nucler Medicine Centre, Centrl Mnchester University Hospitls, Mnchester, UK nd c Nucler Medicine Deprtment, Royl Free London NHS Foundtion Trust, London, UK P54 Quntittive 11 C methionine PET/CT imging in evlution of bone lesions in cncer ptients SH Helmy, K Tnimoto b nd H Tsujii b South Egypt Cncer Institute, Assiut University, Assiut, Egypt nd b Ntionl Institute of Rdiologicl Sciences, Chib, Jpn P55 An objective mesurement of PET to CT lignment using the NEMA IQ phntom D. Sinclir King s College London, London, UK P56 Survivl outcome fter detection of colorectl recurrence on 18 F FDG PET-CT: 2- yer follow-up H. Ahmed,b, M.K. Nwz b, H. Bshir b nd S.A. Kzmi b Guy s nd St. Thoms Hospitl, London, UK nd b Shukt Khnum Memoril Cncer Hospitl & Reserch Centre, Lhore, Pkistn P57 Evlution of Q.freeze softwre for PET respirtory gting of 18 F-FDG PET-CT ptients with liver lesions D. Ruiz, N. Mulhollnd, A. Almeid, B. Corcorn, A. Eccles nd G Vivin King s College Hospitl NHS Foundtion Trust, London, UK P58 Comprison of PET reconstructions from two mnufcturers with point spred function modelling nd time-of-flight I.S. Armstrong, K.E. Kenny b, L. Rowley b nd D.R. McGown b Centrl Mnchester University Hospitls, Mnchester nd b Oxford University Hospitls, Oxford, UK P59 Bowel mlignncy in FDG PET-CT pictoril review A. Kmil nd R. Gntr Queen s Medicl Centre Nottinghm, Nottinghm, UK P60 A pictoril tls of 18 F-FDG PET/CT stging in oesophgel cncer C. Sit, F.R. Green, G. Gnngesrn b nd T.A. Szyszko b King s College London nd b Guy s nd St Thoms Hospitls NHS Trust, London, UK P61 Pictoril tls of 18 F-FDG PET/CT stging in lung cncer C Sit, F Green, G Gnnsegrn b nd T Szyszko King s College London nd b Deprtment of Nucler Medicine & PET/CT, Guy s nd St Thoms NHS Foundtion Trust, London, UK P62 Intr-rteril 123 I-MIBG injection: unique cse? C. Leung, J. Siddiqui, E. Nowosinsk nd H. Jn Brt s Helth NHS Trust, London, UK P63 18 F-choline PET/MRI in prostte cncer: our initil experience J. Stirling, J. John, V. Goh nd G.J. Cook Kings College London, London, UK P64 Optimistion of hybrid simultneous PET/MRI: our initil experience J. Stirling, J. John, J. McKewn, P. Schleyer, G. Chrles- Edwrds, G.J. Cook nd V. Goh Kings College London, London, UK P65 Orgn specific SPECT ctivity quntifiction from fused deposition modelled 3D MIRD inserts A. Robinson, J. Tipping b, D. Cullen, D. Hmilton b, C. Oldfield nd E. Pge b University of Mnchester, Mnchester nd b The Christie NHS Foundtion Trust, Mnchester, UK P66 Cumultive ctivity estimtion t the voxel level: voxel time ctivity curve genertion effects on the resulting 3D dose distribution E. Pge,b, J. Tipping,b nd D. Hmilton,b The Christie NHS Foundtion Trust nd b The University of Mnchester, Mnchester, UK Pge 34 BNMS 43rd Annul Meeting

35 POSTERS P67 The vlue of sctter correction in the re petbility of SIRT lung shunting nlysis E. Vrzkis, L. Tossici-Bolt, F. Wll, F. Sundrm nd M. Guy University Hospitl Southmpton NHS Trust, Southmpton, Hmpshire, UK P68 An inexpensive, simple nd low-dose method for dministering 177 Lu-DOTATATE D. Gillett nd S. Herd Addenbrookes Hospitl, Cmbridge, UK P69 Rdium-223: introducing new rdionuclide D. Gillett nd S. Herd Addenbrookes Hospitl, Cmbridge, UK P70 Impct of production disruption on newly estblished bone pin pllition service S.L. Johns, S. Greenslde, J. Hrris, J. Thom nd F. Sundrm University Hospitl Southmpton NHS Foundtion Trust, Southmpton, UK P71 Assessment of prognostic fctors ffecting the rdioctive iodine (RAI) outcome in hyperthyroid ptients E. Pngiotidis, P. Chuh, R. Brown, N. Seshdri nd S. Vinjmuri Nucler Medicine, Royl Liverpool University Hospitl, Liverpool, UK P72 Delivering xofigo service to NHS ptients: lessons lerned fter one yer t the royl surrey county hospitl J.W. Scuffhm, F.H. Brrck, S.A. Brry, R.P. Cluss, J. Fieldus, P.J. Hinton, F.J. Horton, J.W. Hubber, T. Juleff, S.L. Mnoy, S.J. McQuid, J.L. Merrett, J. Money-Kyrle nd A.J. Smout Royl Surrey County Hospitl, Guildford, Surrey, UK P73 Rdioctive iodine therpy following weight loss surgery: prcticl considertions N. Mulhollnd, L. Devlin, D. Ruiz, E. Kloginni, B. Corcorn, G. Clrke, A. Eccles nd G. Vivin King s College Hospitl NHS Foundtion Trust, London, UK P74 Our experience with the use of 90 Y-SPECT/CT nd 90 Y-PET/CT in the ssessment of 90 Y microsphere biodistribution fter trnsrteril rdioembolistion therpy P.S. Chuh, R. Brown, I. Hufton, G.O. Jones nd S. Vinjmuri Nucler Medicine Deprtment, Royl Liverpool University Hospitl, Liverpool, UK P75 The king s method for infusion pump dministrtion of lutther peptide receptor rdionuclide therpy B. Corcorn, E. Kloginni, D. Ruiz, N. Mulhollnd, A. Eccles nd G. Vivin King s College Hospitl NHS Foundtion Trust, London, UK P76 Hemtotoxicity of 177 Lu dot-octreotte therpy t 6 months nd 2.5 yers nd overll survivl N. Mulhollnd, N.S.A. Rfr, M. Usmn, E. Kloginni, D. Ruiz, B. Corcorn, L. Devlin, N. Gulliver, A. Eccles nd G. Vivin King s College Hospitl NHS Trust, London, UK P77 Ressessment of rdition restrictions following xofigo ( 223 R dichloride) therpy M.J. Guy, B. Johnson, S. Johns b nd F.X. Sundrm b Medicl Physics, University Hospitl Southmpton nd b Nucler Medicine, University Hospitl Southmpton, Southmpton, UK P78 Five yers of moleculr rdiotherpy (MRT) growth in the UK: survey results from 2007 to 2012 B. Rojs,b, C. Hooker b,c, D.R. McGown b,d nd M.J. Guy b,e Royl Brompton Hospitl, London, b Internl Dosimetry Users Group, UK, c Kent nd Cnterbury Hospitl, Kent, d Oxford University Hospitls NHS Trust, Oxford nd e University Hospitl Southmpton, Southmpton, UK P79 Hndling rdium which syringe shield should i use? S. Atkinson nd I. Driver Newcstle upon Tyne NHS Foundtion Trust, Newcstle upon Tyne, UK P80 Revisiting the therpeutic potentil of gllium-67 M. Othmn,b, S. Terry nd P. Blower King s College London, London, UK nd b UiTM, Selngor, Mlysi P81 Rdionuclide neuroendocrine therpy in district hospitl setting C. Lory, P. Ryn nd C. Bowen Medwy Mritime Hospitl, Gillinghm, UK P82 Which phrmcologicl stress gent to use in ptient with porphyri? A cse report with literture review A.V. Grundy, A. Hosur, A. Clrke, H.M. Cripps nd S. Dizdrevic Brighton nd Sussex University Hospitls NHS Trust, Brighton, UK P83 Experience with qulifiction of Lur rdiochromtogrm scnner R. Hrrison, M. Grenn nd J. Crosdle Sndwell nd West Birminghm Hospitls NHS Trust, Birminghm, UK BNMS 43rd Annul Meeting Pge 35

36 POSTERS P84 Optimising ptient pthwy for rdium-223 therpy of bony metstses S. Atkinson, I. Driver, J. Frew, R. McMenemin, A. Azzbi nd I. Pedley Newcstle upon Tyne Hospitls NHS Foundtion Trust, Newcstle upon Tyne, UK P85 Rdionuclide imging of hemtogenously distributed Stphylococcus Aureus infectious foci nd biodistribution of trcers in domestic pigs P. Afzelius, O.L. Nielsen b, A.K.O. Alstrup c, H.C. Schønheyder d,e nd S.B. Jensen f University Hospitl of Copenhgen, North Zelnd Hospitl, Deprtment of Dignostic Imging, Copenhgen, Denmrk, b Univerity of Copenhgen, Veterinry Disese Biology, Copenhgen, Denmrk, c University Hospitl of Arhus, Deprtment og Nucler Medicine nd PET Centre, Arhus, Denmrk, d University Hospitl of Alborg, Deprtment of Clinicl Microbiology, Alborg, Denmrk, e University Hospitl of Alborg, Deprtment of Clinicl Medicine, Alborg, Denmrk nd f University Hospitl of Alborg, Deprtment of Nucler Medicine, Alborg, Denmrk. P86 The serch for n optiml pproch to postsurgicl 131 I thyroid remnnt bltion V.R. McCredy, G. Flux b, A. Hosur, A. Nhum c nd S. Dizdrevic Royl Sussex County Hospitl, Brighton E Sussex, UK, b Institute of Cncer Reserch, Sutton Surrey, UK nd c The Cltterbridge Cncer Centre, Bebington, Wirrl, UK P87 Lbelling efficiency of cheese s n lterntive mel for solid gstric emptying scintigrphy S. Rnderson, S. Renn nd G. Wright Hull nd Est Yorkshire Hospitls NHS Trust, Cottinghm, UK P88 Prcticl, technicl nd rdition protection fctors influencing PRRT NET therpy service: the expnded role of the technologist R. Leshen, I. Mteo-Vito nd S. Nvlkissoor Royl Free London NHS Foundtion Trust, London, UK P89 Renl prenchyml nlysis: 99m Tc-MAG3 versus 99m Tc-DMSA T. De Sous nd D. Biley Guy s nd St Thoms NHS Foundtion Trust, London, UK P90 Rdition protection dvice for nurses looking fter rdionuclide therpy ptients S.L. Johns, R. Pinhorne, C. Joy, B. Johnson nd D. Sggs University Hospitl Southmpton NHS Foundtion Trust, Southmpton, UK P91 Pitflls nd technicl rtefcts in infrequently performed physiologicl nucler medicine tests E. Sung, I. Mteo-Vito nd S. Nvlkissoor Royl Free London NHS Foundtion Trust, London, UK P92 Octreotide or dottte: is there ny difference? S. Johnson nd D. Biley Guys nd St Thoms Hospitl, London, UK P93 Perls nd pitflls in heptobiliry scintigrphy protocols in lrge teching hospitl - trinee technologist s perspective N. Pereir, A. Cheethm, N. Gulliver, A. Eccles, N. Mulhollnd nd G. Vivin King s College Hospitl NHS Foundtion Trust, London, UK P94 Adjusting to chnge: our experience of chnging from 99m Tc-DTPA to 51 Cr-EDTA for GFR studies J. Wilkins, G. Lewis, M.J. Guy nd S. Johns University Hospitl Southmpton NHS Foundtion Trust, Southmpton, UK P95 Experiences of n on-site cyclotron in neurologicl imging A.R. Cbrl, J. O Doherty, J. John, A. Jcob, C. Abreu, S. Pereir nd L. Alves PET Imging Centre, Division of Imging Sciences nd Biomedicl Engineering, King s College London, King s Helth Prtners, St Thoms Hospitl, London, UK P96 Sentinel node injections: n udit of injected ctivities A. Boyce Portsmouth Hospitls NHS Trust, Portsmouth, UK P97 Estblishing locl dose reference levels within peditric SPECT-CT: single centre experience B. Thurlow, E. O Mhoney, L. Bissoni nd C. Young Gret Ormond Street Hospitl for Children NHS Foundtion Trust, London, UK P98 Monte crlo modelling 90 Y SPECT for moleculr rdiotherpy C. Oldfield, D. Cullen, A. Robinson, J. Tippingb, D. Hmiltonb nd E. Pgeb University of Mnchester nd b The Christie NHS Foundtion Trust, Mnchester, UK P99 Erroneous sctter correction on FDG PET study of ptient with ctivity in nephrostomy dringe bg I.S. Armstrong, K.J. Sint nd J.M. Jmes Centrl Mnchester University Hospitl, Mnchester, UK Pge 36 BNMS 43rd Annul Meeting

37 POSTERS P100 Cyclotron production of the positron emitting rdiometl yttrium 86 C. Mrshll, A. Dbkowski nd M. Tlboys,b Crdiff University, Crdiff nd b Crdiff nd Vle UHB, Crdiff, UK P101 Commissioning of new SeHCAT detector nd comprison with n uncollimted gmm cmer J. Himsworth, J. Tylor nd P. Hillel Sheffield Teching Hospitls NHSFT, Sheffield, South Yorkshire, UK P102 Blood dosimetry for rdioiodine thyroid bltion K. Thomson nd A. Hllm Oxford University Hospitls NHS Trust, Oxford, UK P103 Comprison of the quntifiction of 18 F for rdionuclide clibrtor, pre-clinicl PET-CT scnner nd gmm counter J.M. Price,b, I. Murry c nd M.O. Lech,b Institute of Cncer Reserch, London, UK, b CR-UK Cncer Imging Centre, London, UK nd c Royl Mrsden Hospitl NHS Trust, London, UK P104 Evlution of the performnce of pre-clinicl PET-CT scnner using 64 Cu, with comprison to 18 F J.M. Price,b, I. Murry c nd M.O. Lech,b Institute of Cncer Reserch, b CR-UK Cncer Imging Centre nd c Royl Mrsden Hospitl NHS Trust, London, UK P105 Assessing the effects of plnr stonish processing on clinicl bone nd thyroid imges N. Dvis Mount Vernon Hospitl, Northwood, Middlesex, UK P106 The impct of bckground rtios in clibrtion phntoms on the ccurcy of dosimetry for 90 Y DOTATATE therpy T. Snderson,b, J. Ger b, I. Murry b nd G. Flux b St George s Helthcre NHS Trust nd b The Royl Mrsden NHS Foundtion Trust, London, UK P107 Low nd medium-energy generl purpose collimtors provide improved detectbility over lowenergy high sptil resolution collimtors for imging neuroendocrine tumours with 123 I mibg R. Gregory, I. Murry, J. Ger, M. Aldridge, L. Fowkes, W. Wddington, S. Chu nd G. Flux Royl Mrsden NHS Foundtion Trust nd Institute of Cncer Reserch, Sutton, UK nd b UCL Institute of Nucler Medicine nd UCL Hospitls NHS Foundtion Trust, London, UK P108 Automtic clibrtor linerity freewre receptor rdionuclide therpy D. Rushforth, J. Keightley b, B. Prtt nd G. Flux The Royl Mrsden NHS Foundtion Trust, London, UK nd b The Ntionl Physicl Lbortory, Teddington, UK P109 How do you mesure intrinsic uniformity on siemens symbi gmm cmer? I.S. Armstrong nd K.J. Sint Centrl Mnchester University Hospitl, Mnchester, UK P110 Chrcteristion of the lynx uto dispensing for 18 F FDG on mobile PET/CT scnner A.G. Irwin, A. Prmiths, A. Dley b nd D. Wrk b St. George s Hospitl, London nd b Allince Medicl Ltd, Wrwick, UK P111 Physicists in the world of rdiophrmcy - novel pproch to RCP QC J. Spekmn, D. Ibbett nd J. Wlker,b Royl Derby Hospitl, Derby nd b University of Sheffield, Sheffield, UK P112 Urinry excretion of 123 I serum myloid P component (SAP) J. Pge nd J. Jones b Ntionl Amyloidosis Centre nd b Royl Free London NHS Foundtion Trust, London, UK P113 Thyroid bltion restriction times ptient specific modelling of retined ctivity nd dose rtes J. Himsworth, M. Singleton nd P. Hrris Sheffield Teching Hospitls NHSFT, Sheffield, South Yorkshire, UK P114 An investigtion into unusul lek test results J. Solomon, A. Moreton nd C. Nottge Colchester Hospitl University Foundtion Trust, Colchester, Essex, UK BNMS 43rd Annul Meeting Pge 37

38 EXHIBITION FLOOR PLAN The British Institute of Rdiology 1 CIRRUS CONTAINMENTS LTD 2 Qdos, brnd of Elektron Technology 3 Brtec Technologies Limited 4 Dignostic Imging Ltd 5 MEDIAM PHARMA 6 The College of Rdiogrphers 7 Philips 8 Byer UK 9 SIEMENS 10 Mllinckrodt 11 ASHBY GORMAN BAKER 12 LbLogic Systems Limited 13 Sirtex Medicl Limited 14 BTG Immunomedics 16 MILbs 17 Pckexe Ltd 18 Bright Technologies Ltd 19 GE Helthcre 20 Allince Medicl Limited 21 Eli Lilly 22 Hermes Medicl Solutions 23 Imging Equipment Limited 24 LINK MEDICAL 25 British Nucler Medicine Society BNMS 43rd Annul Meeting

39 20 EXHIBITOR PROFILES A-Z VISIT THE SCIENTIFIC EXHIBITION IN MAIN HALL And lern ll bout the most recent developments in nucler medicine helthcre MONDAY 27th April , President s Reception TUESDAY 28th My The BNMS gives wrm welcome to ll its existing nd newly joined industry prtners. As the BNMS promotes innovtion nd keeping up to dte with recent developments in the field, close coopertion with the industry leders is essentil. The compnies contribute with their ctive involvement to the success of the society nd its meetings with their continuous support. Allince Medicl Limited Stnd 21 Allince Medicl opertes ntionl network of over 50 MRI, CT nd PET-CT sttic imging centres. In ddition, we provide mobile medicl imging services to over 100 NHS nd independent sector hospitls through our fleet of mobile scnners. In erly 20, long with prtners in collbortive network, we were successful in our bid to provide PET-CT imging services on behlf of the NHS. As result, we will be significntly incresing PET-CT scnning cpbility with n investment of over 85m cross sites in Englnd working in prtnership with the NHS nd independent sector. Allince Medicl lso opertes n integrted ntionl network of four rdioctive isotope production fcilities nd n integrted SPECT rdiophrmceuticl distribution greement (including Mo-99 genertors) s prt of gol to provide secure of supply of rdionuclides / rdiophrmceuticls to UK ptients nd the UK dignostic imging mrket. For further informtion, plese visit our stnd or contct us: Tel: web: or emil: info@llince.co.uk Ashby Gormn Bker Stnd 12 Ashby GB is once gin is very plesed to support BNMS t this yer s conference in Brighton. An independent compny which continues high qulity mintennce nd repir of mny different Gmm Cmer Systems throughout the UK nd severl Europen Countries. Our commitment is totlly customer focused, providing n excellent nd professionl service which is of the highest qulity nd cost-effective of which we re very proud. We look forwrd to welcoming you to our stnd Brtec Technologies Limited Stnd 4 Brtec supply, deliver, instll nd mintin rnge of Clinicl nd Pre-Clinicl Moleculr Imging Systems nd ssocited Accessories, Digitl X-ry Systems, Rdiology C-Arm nd Ultrsound Tbles, Rdition Monitoring, Protection nd Decontmintion Products. Byer UK Stnd 9 Byer HelthCre Phrmceuticls ims to lunch nd develop products tht improve people s qulity of life. To chieve this, Byer Helthcre Phrmceuticls concentrtes on the reserch nd development of innovtive drugs nd novel therpeutic pproches in the mjor therpeutic groups of crdiology, oncology, ophthlmology, hemtology nd gynecologicl therpy. Within oncology, the frnchise includes three mrketing products (Xofigo, Nexvr nd Stivrg ) nd severl compounds in vrious stges of clinicl development. These products reflect the compny s pproch to reserch, which prioritises trgets nd pthwys with the potentil to impct cncer tretment. Our pipeline explores specific tretment pproches for vrious tumors, including such common types of cncer s prostte, lung nd brest cncer, s well s rrer forms like kidney, liver nd thyroid cncer. British Nucler Medicine Society Stnd 26 To chrge up your devices, gin internet ccess nd pick up dditionl copies of our officil journl NMC; plese visit us t the BNMS booth. Delegtes will lso find informtion on membership, future meetings of the BNMS, brochures nd other journls. Bright Technologies Ltd Stnd 19 Bright Technologies Ltd, often known s Bri Tec, hs renowned reputtion for its expertise in Rdition Protection, Rdioctive Mteril Hndling, Shielding, Rdio-Phrmceuticl Q.C., nd MRI Accessories. A key feture of Bri Tec is our Sheffield bsed in-house design nd mnufcturing fcility. We hve wide rnging experience of working with mny NHS Trusts, Further Eduction Institutes nd commercil compnies. Our in-house design tem nd production fcility llows us to tke your ides nd designs, develop them nd, put them into production. This verstility llows Bri Tec to undertke both low nd high volume production runs In ddition we re ble to bespoke mnufcture room instlltions so tht the room spce is optimlly utilised in terms of both spce nd user friendliness. Wht do we men by this? The instlltion fits both the user s requirements nd the room - not the other wy round! For further informtion on our products nd fcilities plese do not hesitte to contct us. BTG Stnd BNMS At BTG we re focused on bringing to mrket innovtive products in specilist res of medicine to better serve doctors nd ptients. Our growing portfolio of Interventionl Medicine products is designed to dvnce the tretment of liver tumours, severe blood clots, vricose veins nd dvnced emphysem, while our Specilty Phrmceuticls portfolio offers ntidotes tht llevite toxicity nd tret rre conditions. BNMS 43rd Annul Meeting 39

40 20 EXHIBITOR PROFILES A-Z Cirrus Continments Ltd Stnd 2 Cirrus Continments is the UK mnufcturer of unique rnge of continment nd septic isoltors. Our experience within the nucler, phrmceuticl nd helthcre industries hs enbled us to develop nd mnufcture isoltor units which combine leding edge technology with modern design. Our isoltor units re ll bsed upon stndrd modulr method of construction, enbling us to stndrdise prts, hrdwre nd control system softwre cross the complete rnge. Compny Website Dignostic Imging Ltd Stnd 5 We specilise in only Nucler Medicine products. Estblished in 2000 we hve welth of experience in Nucler Medicine procedures. We supply SmrtVent (the UK s bestselling rdioerosol delivery system), DDD gmm cmers (dul hed vrible ngle nd whole body, crdic, renl single hed nd mobile single hed) rytest qulity rdiophrmceuticl lbortory equipment ( rdio-tlc, HPLC nd G synthesisers) nd wide rnge of rdiophrmceuticls nd rdioisotopes (Poltom, Jubilnt DrxImge, ITG, Medi-Rdiophrm nd Iso-Tex) for dignostic nd therpy work. Eli Lilly Stnd 22 Lilly, leding innovtion-driven corportion, is developing growing portfolio of phrmceuticl products by pplying the ltest reserch from its own worldwide lbortories nd from collbortions with eminent scientific orgniztions. Hedqurtered in Indinpolis, Ind., Lilly provides nswers --through medicines nd informtion -- for some of the world's most urgent medicl needs. Lilly hs long heritge in the UK, opening its first fcility outside North Americ in London in Tody Lilly hs round 2500 stff in the UK working cross three sites; sles nd mrketing opertion in Bsingstoke, R&D bse in Surrey nd bio-tech mnufcturing fcility in Liverpool. GE Helthcre Stnd 20 GE Helthcre provides trnsformtionl medicl technologies nd services to meet the demnd for incresed ccess, enhnced qulity nd more ffordble helthcre round the world. GE (NYSE: GE) works on things tht mtter - gret people nd technologies tking on tough chllenges. From medicl imging, softwre & IT, ptient monitoring nd dignostics to drug discovery, biophrmceuticl mnufcturing technologies nd performnce improvement solutions, GE Helthcre helps medicl professionls deliver gret helthcre to their ptients. Hermes Medicl Solutions Ltd Stnd 23 HERMES Medicl Solutions, estblished in 1976 by Jn Bertling, Founder nd President, hs been first-to-mrket with over 88 medicl softwre pplictions, including the first SPECT reconstruction softwre in 1977 nd, in 2014, the ltest milestone: HERMES SUV SPECT With HERMES it is now lso possible to obtin Stndrdized Uptke Vlue (SUV) for SPECT studies. HERMES lunched its unique HERMES SUV SPECT softwre pckge t the 2014 EANM in Gothenburg, Sweden. Works with your existing nd new SPECT/CT systems Avilble on HERMES Cloud nd HERMES Worksttions / Servers. Stte-of-rt SPECT reconstruction lgorithm with ttenution correction, Monte-Crlo-bsed sctter correction nd resolution recovery Avilble for ll routine cliniclly-used rdionuclides nd collimtors. Fster esier nd more relible visul imge comprison Enbles quntittive comprison of SPECT scns without need for dditionl normlistion Improved imge qulity Reduce rdition dose or cquisition time Plese join us on Booth 23 to find out more bout this revolution in Nucler Medicine imging! Imging Equipment Limited Stnd 24 Imging Equipment Limited (IEL) is the lrgest independent distributor of specilist Nucler Medicine products in the UK nd Irelnd nd offers wide portfolio of products including Rdiophrmceuticls, PET injectors, Rdionuclide Therpies, shielding nd rdition protection. IEL re extremely proud to be representing such globl mrket leders in the Nucler Medicine ren s; Advnced Accelertor Applictions (AAA)*, Cyclomedic, Eckert & Ziegler, ROTOP nd Tem, thus being ble to ccurtely mtch customers requirements nd build pckges tht meet both their technicl specifictions nd budgetry demnds. IEL s tem of specilist Nucler Medicine sles consultnts, supported by dedicted nd experienced technicl tem, provide personl nd high-qulity customer service cross the UK nd Irelnd.*Imging Equipment Limited is owned by Advnced Accelertor Applictions (AAA) of St Genis Pouilly (Frnce). Immunomedics Stnd 16 Immunomedics GmbH is subsidiry of Immunomedics, Inc., New Jersey bsed biophrmceuticl compny primrily focused on the development of monoclonl, ntibody-bsed products for the trgeted tretment of cncer, utoimmune nd other serious diseses. The compny hs developed number of dvnced proprietry technologies to crete humnized ntibodies tht cn be used either lone in unlbeled or nked form, or conjugted with rdioctive isotopes or chemotherpeutics, in ech cse to crete highly trgeted gents. The Europen hedqurters is Mrketing Authoristion Holder of LeukoScn, n ntibody for Tc lbelling, pproved for the scintigrphic dignosis of osteomyelitis including dibetic feet. As n ntibody Frgment it does not cuse HAMA s known for intct mouse ntibodies. LeukoScn is distributed by Immunomedics GmbH into more thn 20 countries including UK. LbLogic Systems Ltd Stnd 13 LbLogic provide rnge of mrket leding products which cn be found in some of the world s most prestigious PET nd Nucler Medicine lbortories. Our products include rnge of QC equipment including innovtive r-tlc, r-hplc instruments nd single point of control rdiochromtogrphy softwre pckge Lur for PET. Furthermore Lblogic offer PETr, purpose built PET LIMS system designed to improve efficiency nd complince. PETr directly cptures dt from ll the equipment used. It cts s centrl repository ll informtion within PET production including btch record mngement, QMS, trending, inventory, instrument mintennce etc. Link Medicl Ltd Stnd 25 Link Medicl specilise in medicl imging, rchiving nd connectivity solutions. We provide off-the shelf nd customer specified softwre solutions cross rdiology, nucler medicine nd rdiotherpy. We work for hospitl deprtments, the privte sector nd ll the lrge medicl equipment mnufctures, within the UK, Europe, North Americ nd Jpn. Pge 40 BNMS 43rd Annul Meeting

41 20 EXHIBITOR PROFILES A-Z Mllinckrodt Stnd 11 With history of more thn 1 yers, we re globl leder in medicl imging specilising in rdioctive isotopes nd phrmceuticls for nucler medicine nd dignostics. We re delighted to be supporting the BNMS this yer nd will be holding regulr on-stnd eduction presenttions to show you wht we re doing to help stbilise the supply of Molybdenum for the future. Check the screen on our stnd for presenttion times. Medim Phrm Stnd 6 Medim Phrm is phrmceuticl compny creted in November 2000, bsed in Frnce nd United Kingdom, nd specilised on the commercilistion of rdiophrmceuticl products used in the field of nucler medicine s trcers in medicl imging for dignostic use. The compny is mrketing ll these products in Europe (United Kingdom, Irelnd, Frnce, Netherlnds, Sweden, Finlnd, Portugl, Spin, Greece, etc.), in Asi nd in the Middle Est. We specilise in only Nucler Medicine products. Estblished in 2000 we hve welth of experience in Nucler Medicine procedures. We supply SmrtVent the UK s bestselling rdioerosol delivery system), DDD gmm cmers (dul hed vrible ngle nd whole body, crdic, renl single hed nd mobile single hed) rytest qulity rdiophrmceuticl lbortory equipment ( rdio-tlc, HPLC nd G synthesisers) nd wide rnge of rdiophrmceuticls nd rdioisotopes (Poltom, Jubilnt DrxImge, ITG, Medi-Rdiophrm nd Iso-Tex) for dignostic nd therpy work. MILbs Stnd 17 MILbs provides high-end nd hybrid moleculr imging systems (PET,SPECT, CT) for biomedicl reserch.tody these MILbs systems, with proven qurter-mm SPECT nd three-qurter mm PET resolution, contribute worldwide to the development of new dignostic solutions nd therpies for diseses such s dibetes, cncer, crdic nd neurodegenertive diseses. MILbs U-SPECT4CT provides reserchers by fr the fstest, most sensitive nd highest resolution smll-niml SPECT imging currently vilble nd comes with low dose ultr-high resolution integrted CT. The VECTor option for this system enbles simultneous nd ultr-high resolution PET nd SPECT. MILbs systems hve in common tht they re extremely relible, verstile, nd user friendly. Pckexe Ltd Stnd 18 Pckexe Ltd is UK-bsed compny specilising in protection films for the trde, sfety, helth nd consumer mrkets. Estblished in 1989, the compny s diverse portfolio includes Pckexe Smsh, Shrpswrp, flooring nd multi-surfce protection films, Hndy Wrp nd Physio Wrp. The compny is known for its commitment to qulity nd constnt innovtion producing relible, ffordble nd indispensible products. Pckexe is the world s leding supplier of innovtive protection films. The highly wrded product rnge is seen s the best vilble in sectors rnging from Fire nd Rescue nd Nucler Medicine to Wrehousing nd Construction. Philips Stnd 8 At Philips we re dedicted to creting the future of helthcre nd sving lives. Our understnding nd delivery of clinicl solutions cross the entire helthcre continuum, from helthy living nd prevention to recovery nd long-term mngement t home mens we cn crete more effective, integrted cre solutions. Come nd sk us bout the first instlltion of the world s first Digitl PET/CT Scnner, Philips Vereos. The Vereos provides improved contrst nd superb SUV quntittion while delivering fst scns nd fst post-processing to speed up your workflow. Qdos, brnd of Elektron Technology Stnd 3 Qdos supplies wide rnge of rdiology, dosimetry, QA nd other ssocited products to the medicl, hospitl nd reserch sectors. Qdos is focused on providing premium products in the res of rdiotherpy, nucler medicine, x-ry, Oncology, helth physics nd rdition monitoring. Qdos is the exclusive UK distributor for mny of the key mnufcturers in these sectors. We lso provide services to mny mjor UK nd Irish hospitls nd institutions for the instlltion nd on-going mintennce of instlled systems Including; clibrtions for test equipment nd rdition monitors. Comprehensive support contrcts for equipment re lso offered vi our field bsed service engineers. Siemens Stnd 10 Siemens Helthcre is one of the world's lrgest suppliers to the helthcre industry nd trendsetter in medicl imging, lbortory dignostics, medicl informtion technology nd hering ids. Siemens offers its customers products nd solutions for the entire rnge of ptient cre from single source - from prevention nd erly detection to dignosis, nd on to tretment nd ftercre. By optimising clinicl workflows for the most common diseses, Siemens lso mkes helthcre fster, better nd more cost-effective. Sirtex Stnd 14 Sirtex Medicl Europe GmbH is wholly-owned subsidiry of Sirtex Medicl Limited, publicly-listed compny on the Austrlin Securities Exchnge engged in the field of liver-directed therpies for oncology. Our innovtive technology, SIR-Spheres microspheres, ws pproved in 2002 for use in the tretment of unresectble liver tumours within the Europen Union under CE Mrk nd for the tretment of colorectl cncer liver metstses in combintion with FUDR intr-rteril chemotherpy by the US Food & Drug Administrtion. SIR-Spheres microspheres re presently used to tret vriety of unresectble liver metstses s well s in heptocellulr crcinom t over 100 institutions throughout Europe. For more informtion, plese contct Hed Office: Sirtex Medicl Europe GmbH Joseph-Schumpeter-Allee Bonn, Germny Tel: The British Institute of Rdiology Stnd 1 The BIR is the oldest rdiologicl society in the world which welcomes everyone working in the field of rdiology, rdition oncology nd the underlying sciences. Whether you re rdiologist, rdiogrpher, medicl physicist, rdiotherpist, oncologist or nyone with professionl interest in the field, there is membership ctegory to suit your needs. The College of Rdiogrphers Stnd 7 The College of Rdiogrphers is committed to developing nd promoting wider understnding of the science of clinicl imging nd rdition therpy. We promote the ccredittion of professionl stndrds cross the imging nd rdiotherpy workforce nd im to build professionl credibility through reserch. We wnt to be informed by our ptients nd lso help our ptients nd public to better understnd the role of imging nd rdiotherpy in their helthcre. We seek to collborte nd prtner on globl bsis to ensure tht the very best stndrds of prctice re shred for the benefit of ll. A mjor feture of our eductionl work recently hs been the development of e-lfh lerning units for nucler medicine prctitioners come nd see these excellent resources on our stnd. We welcome visitors to our stnd where representtives will be on hnd to discuss wide rnge of topics, including regultion, workforce shortges nd development, hybrid imging skills, continuing professionl development, etc. So, plese visit us members nd nonmembers re ll very welcome. BNMS 43rd Annul Meeting Pge 41

42 VENUE PLAN North Lifts To cr prks nd shopping centre Syndicte Wing Entrnce Security Desk North Lifts Meeting Room 3 Office 4 Meeting Room 5 Meeting Room 14 North Lifts Syndicte 1 & 2 Syndicte Wing Medicl Room Syndicte 3 & 4 Syndicte Wing Meeting Room 1 West Br Exhibition Auditorium 1 Est Br Exhibition Auditorium 1 Foyer Informtion Desk Box Office South Lifts To sefront 2Br Auditorium 2 Office 2 South Lifts AV Preview Room Ground Floor First Floor Second Floor 42 BNMS 43rd Annul Meeting

43 ce oug Mrl bor Ro d P Bu vilio ild i n gn s l Pl Pl t Blck Steps This tle Hotel K ing s Rod mew e lc P Ln ne Vi ei e e re ri nt St holo ne u s d Brt ei Sq Ol et A rcd St le Ste in G rd Ol d tei ne ey Lion S treet Ship T he L nes Stre st ol Po s g P d Est Stree Ro P v on ght Bri et t Est s t C St r e e Brighton Town Hll T Br tholomew Squre Steps King Stre e t S tre e Lne Pr i P l n c e s ce Ln Friends M ee ting House Nile v Gr Indi G te Es Lion Ju i lee e e t et New Blck et Steps TH E r e L ANES Est S t s S E A F RO NT T Steps e us Ho ng B r ighton S qu re Little den Stre ic et G r G Brig M s Mu A r t G lle r Brighton Dome Royl rt h St ket Stre Yd t eet et Ship ce eti Str Stre d th S tre Jew Bon et re ion St C Old Cour troo CU C U LT U R A L QChUA UpeA RTER RT ER l et Sou Ro Thetre Royl St Un ren re The Sefront O f f ice g s d S tre Plc King Ship St L ser zone St Ro w Mr d Pr in Rege S in Compl omp ex e ip es L ne M i d d l e St re e t Syngogue Kin Stre t Stree King Po r t l dsor e St Pul ls Church Ro d St Lin Sh C ll et re le St Duk Mi dd F b r i c t Trinit y Church rt We s t Pie r et Jubi e r Corn Studio Co Thetre E xchnge Unitrin Church be Bech Volleybll e Al Steps sg s Stre et The Gr G nd Cre tive Qur te r nd S tre Stre et t Str e Wes Boyce Street sell Brighton Centre d Steps P s et ce Ro e s Bond in Po o l V l l Co Co Stti t Fishing M useu e m Brills Ln Steps g s e St re Middle d Steps Plyg roun ound d Win le S t nvil Ro Rus Kin Gre e Plc sell Bon sell Rus Rus e Plc non Mew s Duk th S tre K et C hurch Stre e t Pr Subwy h S tre st re et ion Squre Queen Plc e Churchill S qu re C r Prk 1 Shopmobili t y Russ e ll Rod Cn ury Duk Duk Cou e s rt ncy R od re Rege ency ensb Cllock C Tower n Rod C h u rc h i l l S q u re Shopping Centre Churchil hi l S qu re C r Prk 2 Reg Rege nc y Squre r et Steps Cn Russe ll Squ re re Ai re St Nor non s urc i l n Rege tle S tree t Cl re nce S qur qu re qure Squ re Squ Rege ish end Cv Steps Wester u e o ncy Plc e ent Rege n c y S qu re et Ch Brig Bud C Me t St l o o g Mr et Cro et Stre Steps et Imperil A rc n BRIGHTON MAP N Ori Mew Que Bnds t nd Stre le S tre ncy S qu Pre l P lc Squ ord Rege ston t e re d S tree ency ne Cs d d R o woo elie ntp Mo Cst Sill woo r Sill Brig r htton on Hot H otel S Nichol s C urch Wes r R o d d P l for Bed Sto Reg ps e t De o REG R EG E N NC CY ree B t wn S tre t n S tr mpt tern c stern r mp ton o r or S r in e i r e r r edf o t G rd e n R Steps Steps G rossv ve n o C sino on R i t c Grnd Jun A r tis t s Qur te r Brighto Pie About 5 min wlk BNMS 43rd Annul Meeting 43

44